|
OMIM |
Link |
Information gain |
01 |
|
fatty metamorphosis of viscera
|
[NCBI]
|
0.00523388
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.00362047
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.0031135
|
|
|
CAT
|
[NCBI]
|
0.00271621
|
|
|
LPL
|
[NCBI]
|
0.00255581
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.00225254
|
|
|
AFP
|
[NCBI]
|
0.00212062
|
|
|
hyperbilirubinemia, rotor type
|
[NCBI]
|
0.00208256
|
|
|
antipyrine metabolism
|
[NCBI]
|
0.00208256
|
|
|
renal-hepatic-pancreatic dysplasia with dandy-walker cyst
|
[NCBI]
|
0.00208256
|
|
|
geleophysic dysplasia
|
[NCBI]
|
0.00206529
|
|
|
DJS
|
[NCBI]
|
0.00196157
|
|
|
HGF
|
[NCBI]
|
0.00173963
|
|
|
carnosinemia
|
[NCBI]
|
0.00165632
|
|
|
letterer-siwe disease
|
[NCBI]
|
0.00165632
|
|
|
gangliosidosis, gm2, type iii, or juvenile type
|
[NCBI]
|
0.00165632
|
|
|
CYP1A1
|
[NCBI]
|
0.00157923
|
|
|
APOB
|
[NCBI]
|
0.00154896
|
|
|
LIPC
|
[NCBI]
|
0.00148595
|
|
|
campomelia, cumming type
|
[NCBI]
|
0.00146485
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
0.00146428
|
|
|
NGFB
|
[NCBI]
|
0.0014628
|
|
|
RA
|
[NCBI]
|
0.00120955
|
|
|
reticuloendotheliosis, x-linked
|
[NCBI]
|
0.00103949
|
|
|
hyperphosphatasia with mental retardation
|
[NCBI]
|
0.00103949
|
|
|
ethanolaminosis
|
[NCBI]
|
0.00103949
|
|
|
PFIC1
|
[NCBI]
|
0.000992559
|
|
|
TH
|
[NCBI]
|
0.000966144
|
|
|
gilbert syndrome
|
[NCBI]
|
0.000944961
|
|
|
NPY
|
[NCBI]
|
0.000904105
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
0.000853203
|
|
|
NR1I2
|
[NCBI]
|
0.000830243
|
|
|
VEGF
|
[NCBI]
|
0.000807799
|
|
|
glycogen storage disease iv
|
[NCBI]
|
0.000797431
|
|
|
glycogen storage disease iii
|
[NCBI]
|
0.000783066
|
|
|
ARPKD
|
[NCBI]
|
0.000778967
|
|
|
CRH
|
[NCBI]
|
0.000767219
|
|
|
AHR
|
[NCBI]
|
0.000744819
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
0.000734815
|
|
|
USH1E
|
[NCBI]
|
0.000730668
|
|
|
acromicric dysplasia
|
[NCBI]
|
0.000730668
|
|
|
adrenal unresponsiveness to acth
|
[NCBI]
|
0.000730668
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000730668
|
|
|
d-glyceric acidemia
|
[NCBI]
|
0.000730668
|
|
|
BDNF
|
[NCBI]
|
0.000704961
|
|
|
LCAT
|
[NCBI]
|
0.00068251
|
|
|
wilson disease
|
[NCBI]
|
0.000674558
|
|
|
ABCB11
|
[NCBI]
|
0.000670662
|
|
|
PC
|
[NCBI]
|
0.000655324
|
|
|
GFAP
|
[NCBI]
|
0.000644262
|
|
|
CHAT
|
[NCBI]
|
0.000643292
|
|
|
NPC1
|
[NCBI]
|
0.000636873
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
0.000629022
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
0.000627945
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
0.000617559
|
|
|
saccharopinuria
|
[NCBI]
|
0.000615459
|
|
|
hydroxykynureninuria
|
[NCBI]
|
0.000615459
|
|
|
blue rubber bleb nevus
|
[NCBI]
|
0.000615459
|
|
|
USH2B
|
[NCBI]
|
0.000615459
|
|
|
ZS
|
[NCBI]
|
0.000608494
|
|
|
PPARA
|
[NCBI]
|
0.000588906
|
|
|
neuraminidase deficiency
|
[NCBI]
|
0.000571901
|
|
|
CP
|
[NCBI]
|
0.000549272
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
0.000549142
|
|
|
AD
|
[NCBI]
|
0.000548825
|
|
|
GPT
|
[NCBI]
|
0.000545514
|
|
|
ALB
|
[NCBI]
|
0.000541709
|
|
|
trichohepatoenteric syndrome
|
[NCBI]
|
0.000541406
|
|
|
PI
|
[NCBI]
|
0.000538663
|
|
|
PTH
|
[NCBI]
|
0.000531621
|
|
|
bile acid synthesis defect, congenital, 2
|
[NCBI]
|
0.000524757
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
0.000524757
|
|
|
GHR
|
[NCBI]
|
0.000518448
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
0.000507414
|
|
|
ABCC2
|
[NCBI]
|
0.000499099
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
0.000496568
|
|
|
IGFALS
|
[NCBI]
|
0.000491074
|
|
|
methylmalonic aciduria and homocystinuria, cblf type
|
[NCBI]
|
0.000486897
|
|
|
CLN4A
|
[NCBI]
|
0.000486897
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
0.000484826
|
|
|
ATD1
|
[NCBI]
|
0.000481119
|
|
|
CCK
|
[NCBI]
|
0.00047825
|
|
|
carnitine palmitoyltransferase i deficiency
|
[NCBI]
|
0.000469581
|
|
|
citrullinemia, classic
|
[NCBI]
|
0.000466953
|
|
|
GNMT
|
[NCBI]
|
0.000455396
|
|
|
ABL
|
[NCBI]
|
0.000449227
|
|
|
ALGS1
|
[NCBI]
|
0.000449136
|
|
|
XDH
|
[NCBI]
|
0.000442143
|
|
|
aceruloplasminemia
|
[NCBI]
|
0.000441911
|
|
|
KLK3
|
[NCBI]
|
0.00043264
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
0.000419762
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
0.000415535
|
|
|
AVP
|
[NCBI]
|
0.000411578
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000408513
|
|
|
renal hamartomas, nephroblastomatosis, and fetal gigantism
|
[NCBI]
|
0.000408513
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
0.000407513
|
|
|
gtp cyclohydrolase i deficiency
|
[NCBI]
|
0.000407513
|
|
|
CTLN2
|
[NCBI]
|
0.000407513
|
|
|
MBP
|
[NCBI]
|
0.000398195
|
|
|
sandhoff disease
|
[NCBI]
|
0.00039037
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
0.000386802
|
|
|
tyrosinemia, type i
|
[NCBI]
|
0.000385995
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
0.000378531
|
|
|
cranioectodermal dysplasia
|
[NCBI]
|
0.000378531
|
|
|
halothane hepatitis
|
[NCBI]
|
0.000376922
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
0.000365952
|
|
|
GCE
|
[NCBI]
|
0.00036453
|
|
|
PDV
|
[NCBI]
|
0.00036453
|
|
|
EGFR
|
[NCBI]
|
0.000361345
|
|
|
TTR
|
[NCBI]
|
0.000355937
|
|
|
constricting bands, congenital
|
[NCBI]
|
0.000352592
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
0.000352592
|
|
|
HFE
|
[NCBI]
|
0.000351204
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
0.000349579
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
0.000349579
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
0.000345635
|
|
|
refsum disease, infantile form
|
[NCBI]
|
0.000336318
|
|
|
argininemia
|
[NCBI]
|
0.00032481
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
0.00032481
|
|
|
SERPINA6
|
[NCBI]
|
0.000317465
|
|
|
FHCA
|
[NCBI]
|
0.000314788
|
|
|
refsum disease
|
[NCBI]
|
0.000313614
|
|
|
phosphorylase kinase deficiency of liver and muscle, autosomal recessive
|
[NCBI]
|
0.000312968
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
0.000312968
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
0.000312406
|
|
|
NPPA
|
[NCBI]
|
0.000312267
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
0.000311109
|
|
|
ATHS
|
[NCBI]
|
0.000309497
|
|
|
CDO
|
[NCBI]
|
0.000306593
|
|
|
GDNF
|
[NCBI]
|
0.000295905
|
|
|
CFTR
|
[NCBI]
|
0.000295609
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
0.000293489
|
|
|
cirrhosis, familial
|
[NCBI]
|
0.000286438
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
0.000286438
|
|
|
porphyria cutanea tarda, type i
|
[NCBI]
|
0.000286438
|
|
|
ASS
|
[NCBI]
|
0.000285286
|
|
|
FBS
|
[NCBI]
|
0.00028499
|
|
|
G6PD
|
[NCBI]
|
0.00028213
|
|
|
COMT
|
[NCBI]
|
0.000281263
|
|
|
sialuria, finnish type
|
[NCBI]
|
0.000267726
|
|
|
HP
|
[NCBI]
|
0.000261424
|
|
|
HNF1A
|
[NCBI]
|
0.00025979
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000259789
|
|
|
PCOS1
|
[NCBI]
|
0.000259617
|
|
|
wolman disease
|
[NCBI]
|
0.00025797
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
0.000252852
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
0.000252821
|
|
|
iron overload in africa
|
[NCBI]
|
0.000251765
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
0.000251765
|
|
|
SHH
|
[NCBI]
|
0.000249685
|
|
|
SCD
|
[NCBI]
|
0.000249049
|
|
|
CDSP
|
[NCBI]
|
0.000247457
|
|
|
AR
|
[NCBI]
|
0.000247245
|
|
|
RBP1
|
[NCBI]
|
0.000246381
|
|
|
CJD
|
[NCBI]
|
0.000241477
|
|
|
gaucher disease, type i
|
[NCBI]
|
0.00023831
|
|
|
PEMT
|
[NCBI]
|
0.000237521
|
|
|
HNF4A
|
[NCBI]
|
0.000237336
|
|
|
LS
|
[NCBI]
|
0.000236801
|
|
|
GJB1
|
[NCBI]
|
0.000231426
|
|
|
PD
|
[NCBI]
|
0.000229576
|
|
|
PCNA
|
[NCBI]
|
0.00022657
|
|
|
bile acid synthesis defect, congenital, 1
|
[NCBI]
|
0.000220859
|
|
|
hyperbilirubinemia, transient familial neonatal
|
[NCBI]
|
0.000220859
|
|
|
RNASE3
|
[NCBI]
|
0.00022071
|
|
|
ADH2
|
[NCBI]
|
0.000212668
|
|
|
MKS4
|
[NCBI]
|
0.000209837
|
|
|
3-@hydroxy-3-methylglutaryl-coa synthase 2, mitochondrial, deficiency of
|
[NCBI]
|
0.000209837
|
|
|
urocanase deficiency
|
[NCBI]
|
0.000209837
|
|
|
long chain fatty acids, defect in transport of
|
[NCBI]
|
0.000209837
|
|
|
asplenia with cystic liver, kidney, and pancreas
|
[NCBI]
|
0.000209837
|
|
|
biliary malformation with renal tubular insufficiency
|
[NCBI]
|
0.000209837
|
|
|
histidinemia
|
[NCBI]
|
0.000208996
|
|
|
SLC6A3
|
[NCBI]
|
0.000206154
|
|
|
VIP
|
[NCBI]
|
0.000205085
|
|
|
isoniazid inactivation
|
[NCBI]
|
0.000204557
|
|
|
LPI
|
[NCBI]
|
0.000202545
|
|
|
CDAN2
|
[NCBI]
|
0.000199804
|
|
|
NAIC
|
[NCBI]
|
0.000199074
|
|
|
NN
|
[NCBI]
|
0.000199074
|
|
|
lactic acidosis, fatal infantile
|
[NCBI]
|
0.000199074
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
0.000198766
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
0.000198766
|
|
|
UGT1A1
|
[NCBI]
|
0.00019546
|
|
|
DHS
|
[NCBI]
|
0.000190171
|
|
|
DHFR
|
[NCBI]
|
0.000189963
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
0.000189509
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000188217
|
|
|
HHT
|
[NCBI]
|
0.000187881
|
|
|
ADH1
|
[NCBI]
|
0.000183155
|
|
|
TFR2
|
[NCBI]
|
0.000182961
|
|
|
sulfocysteinuria
|
[NCBI]
|
0.000182172
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.00018113
|
|
|
CF
|
[NCBI]
|
0.000180784
|
|
|
APC
|
[NCBI]
|
0.00018027
|
|
|
glycogen storage disease i
|
[NCBI]
|
0.000179777
|
|
|
GNRH1
|
[NCBI]
|
0.000178108
|
|
|
ARG1
|
[NCBI]
|
0.000171859
|
|
|
BHMT
|
[NCBI]
|
0.000171859
|
|
|
MODY
|
[NCBI]
|
0.000170714
|
|
|
LDLR
|
[NCBI]
|
0.000170708
|
|
|
BRIC1
|
[NCBI]
|
0.000168368
|
|
|
hyperlysinemia
|
[NCBI]
|
0.000168368
|
|
|
VDR
|
[NCBI]
|
0.000164592
|
|
|
PTK2
|
[NCBI]
|
0.000162643
|
|
|
CD
|
[NCBI]
|
0.00016206
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000159496
|
|
|
RP
|
[NCBI]
|
0.000156726
|
|
|
ARH
|
[NCBI]
|
0.000156717
|
|
|
australia antigen
|
[NCBI]
|
0.000156441
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000155118
|
|
|
fabry disease
|
[NCBI]
|
0.000153706
|
|
|
CES1
|
[NCBI]
|
0.000153701
|
|
|
FA
|
[NCBI]
|
0.000153235
|
|
|
MAT1A
|
[NCBI]
|
0.000151692
|
|
|
TNFRSF11B
|
[NCBI]
|
0.000151382
|
|
|
PRL
|
[NCBI]
|
0.000149586
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
0.000146657
|
|
|
gracile syndrome
|
[NCBI]
|
0.000146657
|
|
|
hypoascorbemia
|
[NCBI]
|
0.000146657
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
0.000146657
|
|
|
sudden infant death syndrome
|
[NCBI]
|
0.000146657
|
|
|
NR1H4
|
[NCBI]
|
0.000145809
|
|
|
EGF
|
[NCBI]
|
0.00014559
|
|
|
ACADM
|
[NCBI]
|
0.000144667
|
|
|
TF
|
[NCBI]
|
0.000141892
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
0.000141093
|
|
|
ALDH2
|
[NCBI]
|
0.000137234
|
|
|
ATP8B1
|
[NCBI]
|
0.000133614
|
|
|
GYS2
|
[NCBI]
|
0.000132838
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
0.000132695
|
|
|
HCHOLA3
|
[NCBI]
|
0.000132695
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
0.000132695
|
|
|
lipase deficiency, combined
|
[NCBI]
|
0.000132695
|
|
|
n-acetylglutamate synthase deficiency
|
[NCBI]
|
0.000132695
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
0.000132156
|
|
|
SLE
|
[NCBI]
|
0.000130251
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
0.000129953
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
0.000129953
|
|
|
sitosterolemia
|
[NCBI]
|
0.000129953
|
|
|
UOX
|
[NCBI]
|
0.000129953
|
|
|
ACHE
|
[NCBI]
|
0.000129365
|
|
|
PFKL
|
[NCBI]
|
0.000128609
|
|
|
MADD
|
[NCBI]
|
0.000127499
|
|
|
APOE
|
[NCBI]
|
0.000124801
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.00012466
|
|
|
NR0B2
|
[NCBI]
|
0.000123778
|
|
|
NNMT
|
[NCBI]
|
0.000122685
|
|
|
GAL
|
[NCBI]
|
0.000122564
|
|
|
ADCYAP1
|
[NCBI]
|
0.000116862
|
|
|
hyperpipecolatemia
|
[NCBI]
|
0.000116616
|
|
|
glycogen storage disease 0, muscle
|
[NCBI]
|
0.000116616
|
|
|
ICP
|
[NCBI]
|
0.000116616
|
|
|
HFE4
|
[NCBI]
|
0.000116616
|
|
|
budd-chiari syndrome
|
[NCBI]
|
0.000116616
|
|
|
PBC
|
[NCBI]
|
0.000116616
|
|
|
cerebellar vermis aplasia with associated features suggesting smith-lemli-opitz syndrome and meckel syndrome
|
[NCBI]
|
0.000116616
|
|
|
cystathioninuria
|
[NCBI]
|
0.000116616
|
|
|
pyruvate dehydrogenase phosphatase deficiency
|
[NCBI]
|
0.000116616
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
0.00011646
|
|
|
SLC11A2
|
[NCBI]
|
0.000115566
|
|
|
POMC
|
[NCBI]
|
0.000114384
|
|
|
SLC40A1
|
[NCBI]
|
0.000114241
|
|
|
PLTP
|
[NCBI]
|
0.000113613
|
|
|
SCP2
|
[NCBI]
|
0.000112946
|
|
|
AKR1C4
|
[NCBI]
|
0.000112504
|
|
|
glycogen storage disease vi
|
[NCBI]
|
0.000112504
|
|
|
ADH5
|
[NCBI]
|
0.00011248
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
0.000111345
|
|
|
ALDH1A1
|
[NCBI]
|
0.000111069
|
|
|
PFKFB1
|
[NCBI]
|
0.000110697
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
0.000110595
|
|
|
TNF
|
[NCBI]
|
0.000108132
|
|
|
HSD17B4
|
[NCBI]
|
0.000108018
|
|
|
TSD
|
[NCBI]
|
0.00010528
|
|
|
gangliosidosis, gm2, juvenile, a(m)b variant
|
[NCBI]
|
0.000104907
|
|
|
glycoprotein storage disease
|
[NCBI]
|
0.000104907
|
|
|
PFIC3
|
[NCBI]
|
0.000104907
|
|
|
cirrhosis, familial
|
[NCBI]
|
0.000104907
|
|
|
pancreatitis, sclerosing cholangitis, and sicca complex
|
[NCBI]
|
0.000104907
|
|
|
glycine n-methyltransferase deficiency
|
[NCBI]
|
0.000104907
|
|
|
ovalocytosis, hereditary hemolytic, with defective erythropoiesis
|
[NCBI]
|
0.000104907
|
|
|
hyperlysinemia due to defect in lysine transport into mitochondria
|
[NCBI]
|
0.000104907
|
|
|
acylase, cobalt-activated
|
[NCBI]
|
0.000104907
|
|
|
wolman disease with hypolipoproteinemia and acanthocytosis
|
[NCBI]
|
0.000104907
|
|
|
tremor of intention, ataxia, and lipofuscinosis
|
[NCBI]
|
0.000104907
|
|
|
retinohepatoendocrinologic syndrome
|
[NCBI]
|
0.000104907
|
|
|
trisomy 18-like syndrome
|
[NCBI]
|
0.000104907
|
|
|
anemia, autoimmune hemolytic
|
[NCBI]
|
0.000104907
|
|
|
lactic acidosis, chronic adult form
|
[NCBI]
|
0.000104907
|
|
|
regeneration-associated serpin-1
|
[NCBI]
|
0.000104907
|
|
|
acid phosphatase deficiency
|
[NCBI]
|
0.000104907
|
|
|
myelocytic leukemia-like syndrome, familial, chronic
|
[NCBI]
|
0.000104907
|
|
|
transaldolase deficiency
|
[NCBI]
|
0.000104907
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
0.000104907
|
|
|
phosphatase, acid, of tissues
|
[NCBI]
|
0.000104907
|
|
|
nephropathy, progressive tubulointerstitial, with cholestatic liver disease
|
[NCBI]
|
0.000104907
|
|
|
CDG2B
|
[NCBI]
|
0.000104907
|
|
|
hyperbilirubinemia, conjugated, type iii
|
[NCBI]
|
0.000104907
|
|
|
cyanosis and hepatic disease
|
[NCBI]
|
0.000104907
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
0.000104907
|
|
|
xfe progeroid syndrome
|
[NCBI]
|
0.000104907
|
|
|
epithelial basolateral chloride conductance regulator, rabbit, homolog of
|
[NCBI]
|
0.000104907
|
|
|
liver fibrocystic disease and polydactyly
|
[NCBI]
|
0.000104907
|
|
|
TMAU
|
[NCBI]
|
0.000104458
|
|
|
MODY2
|
[NCBI]
|
0.000104458
|
|
|
HAMP
|
[NCBI]
|
0.000104417
|
|
|
ACP5
|
[NCBI]
|
0.000104107
|
|
|
HD
|
[NCBI]
|
0.000103433
|
|
|
USF1
|
[NCBI]
|
0.000102414
|
|
|
ACADS
|
[NCBI]
|
0.000102105
|
|
|
MDD
|
[NCBI]
|
0.000101481
|
|
|
FPGS
|
[NCBI]
|
0.000101275
|
|
|
AKR1C2
|
[NCBI]
|
0.000101122
|
|
|
MKS1
|
[NCBI]
|
0.000100656
|
|
|
glycogen storage disease ii
|
[NCBI]
|
0.000100429
|
|
|
PTHLH
|
[NCBI]
|
0.000100183
|
|
|
phenylketonuria
|
[NCBI]
|
9.94589e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
9.5599e-05
|
|
|
ALPL
|
[NCBI]
|
9.55402e-05
|
|
|
PCLD
|
[NCBI]
|
9.47159e-05
|
|
|
coumarin resistance
|
[NCBI]
|
9.47159e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
9.47159e-05
|
|
|
CES2
|
[NCBI]
|
9.15686e-05
|
|
|
GUSB
|
[NCBI]
|
9.1507e-05
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
9.12908e-05
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
9.12908e-05
|
|
|
glycogen storage disease ib
|
[NCBI]
|
9.12908e-05
|
|
|
OTC
|
[NCBI]
|
9.07044e-05
|
|
|
SLOS
|
[NCBI]
|
8.98066e-05
|
|
|
F3
|
[NCBI]
|
8.96167e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
8.72626e-05
|
|
|
IL2
|
[NCBI]
|
8.68616e-05
|
|
|
AOS
|
[NCBI]
|
8.66296e-05
|
|
|
GHRH
|
[NCBI]
|
8.57576e-05
|
|
|
UCP2
|
[NCBI]
|
8.48754e-05
|
|
|
PYY
|
[NCBI]
|
8.30788e-05
|
|
|
NR5A2
|
[NCBI]
|
8.30688e-05
|
|
|
HPD
|
[NCBI]
|
8.12183e-05
|
|
|
AMT
|
[NCBI]
|
8.12183e-05
|
|
|
GCSH
|
[NCBI]
|
8.12183e-05
|
|
|
SLC25A13
|
[NCBI]
|
8.12183e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
7.97112e-05
|
|
|
JH
|
[NCBI]
|
7.97112e-05
|
|
|
NIDDM
|
[NCBI]
|
7.90667e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
7.65834e-05
|
|
|
GCK
|
[NCBI]
|
7.4902e-05
|
|
|
PKLR
|
[NCBI]
|
7.44429e-05
|
|
|
ADA
|
[NCBI]
|
7.43079e-05
|
|
|
CYP3A7
|
[NCBI]
|
7.36039e-05
|
|
|
RGN
|
[NCBI]
|
7.36039e-05
|
|
|
krabbe disease
|
[NCBI]
|
7.27383e-05
|
|
|
CYP3A4
|
[NCBI]
|
7.25587e-05
|
|
|
SREBF1
|
[NCBI]
|
7.21028e-05
|
|
|
MAP2
|
[NCBI]
|
7.17627e-05
|
|
|
LRP1
|
[NCBI]
|
7.10734e-05
|
|
|
HAO1
|
[NCBI]
|
7.08779e-05
|
|
|
FBP1
|
[NCBI]
|
7.08779e-05
|
|
|
FTCD
|
[NCBI]
|
7.06067e-05
|
|
|
SLC22A1
|
[NCBI]
|
7.06067e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
7.04242e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
7.02463e-05
|
|
|
SLC2A2
|
[NCBI]
|
6.97645e-05
|
|
|
P4HB
|
[NCBI]
|
6.90182e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
6.84264e-05
|
|
|
sialuria
|
[NCBI]
|
6.84264e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
6.84264e-05
|
|
|
PPARGC1A
|
[NCBI]
|
6.76807e-05
|
|
|
IGFBP1
|
[NCBI]
|
6.75341e-05
|
|
|
ACPP
|
[NCBI]
|
6.70291e-05
|
|
|
CEBPA
|
[NCBI]
|
6.67107e-05
|
|
|
CES3
|
[NCBI]
|
6.64158e-05
|
|
|
VCPIP1
|
[NCBI]
|
6.64158e-05
|
|
|
SLC10A1
|
[NCBI]
|
6.64158e-05
|
|
|
ADHFE1
|
[NCBI]
|
6.64158e-05
|
|
|
CSCI
|
[NCBI]
|
6.63372e-05
|
|
|
cerebrocortical degeneration of infancy
|
[NCBI]
|
6.63372e-05
|
|
|
FPLD3
|
[NCBI]
|
6.63372e-05
|
|
|
JBTS6
|
[NCBI]
|
6.63372e-05
|
|
|
acyl-coa thioester hydrolase, long-chain, 1
|
[NCBI]
|
6.63372e-05
|
|
|
NEK1
|
[NCBI]
|
6.63372e-05
|
|
|
hexokinase of spermatozoa
|
[NCBI]
|
6.63372e-05
|
|
|
carnitine acetyltransferase deficiency
|
[NCBI]
|
6.63372e-05
|
|
|
GUK2
|
[NCBI]
|
6.63372e-05
|
|
|
secretory component deficiency
|
[NCBI]
|
6.63372e-05
|
|
|
chondrodysplasia punctata syndrome
|
[NCBI]
|
6.63372e-05
|
|
|
APOF
|
[NCBI]
|
6.63372e-05
|
|
|
VODI
|
[NCBI]
|
6.63372e-05
|
|
|
alkaline phosphatase, blood group-associated
|
[NCBI]
|
6.63372e-05
|
|
|
glutamyl ribose-5-phosphate storage disease
|
[NCBI]
|
6.63372e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
6.63372e-05
|
|
|
amish infantile epilepsy syndrome
|
[NCBI]
|
6.63372e-05
|
|
|
glutaryl-coa oxidase deficiency
|
[NCBI]
|
6.63372e-05
|
|
|
JMML
|
[NCBI]
|
6.62564e-05
|
|
|
ACOX1
|
[NCBI]
|
6.54329e-05
|
|
|
CNTF
|
[NCBI]
|
6.50808e-05
|
|
|
CDG1A
|
[NCBI]
|
6.48856e-05
|
|
|
AMH
|
[NCBI]
|
6.41995e-05
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
6.37158e-05
|
|
|
OSM
|
[NCBI]
|
6.18787e-05
|
|
|
GRHPR
|
[NCBI]
|
6.17335e-05
|
|
|
GCGR
|
[NCBI]
|
6.17335e-05
|
|
|
AKR1C1
|
[NCBI]
|
6.17335e-05
|
|
|
CYP2E
|
[NCBI]
|
6.17335e-05
|
|
|
ABCC3
|
[NCBI]
|
6.09899e-05
|
|
|
ATP7B
|
[NCBI]
|
6.00155e-05
|
|
|
ACACA
|
[NCBI]
|
6.00155e-05
|
|
|
HEPH
|
[NCBI]
|
6.00155e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
5.98734e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
5.94794e-05
|
|
|
STAT5B
|
[NCBI]
|
5.93272e-05
|
|
|
BL
|
[NCBI]
|
5.85278e-05
|
|
|
GSTM1
|
[NCBI]
|
5.70996e-05
|
|
|
SPP1
|
[NCBI]
|
5.66359e-05
|
|
|
SLC6A4
|
[NCBI]
|
5.64853e-05
|
|
|
ASL
|
[NCBI]
|
5.624e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
5.53133e-05
|
|
|
ADH3
|
[NCBI]
|
5.51515e-05
|
|
|
MTP
|
[NCBI]
|
5.43859e-05
|
|
|
LDLRAP1
|
[NCBI]
|
5.43859e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
5.43859e-05
|
|
|
STAR
|
[NCBI]
|
5.38016e-05
|
|
|
RCDP1
|
[NCBI]
|
5.31837e-05
|
|
|
cortisone reductase deficiency
|
[NCBI]
|
5.22193e-05
|
|
|
FMO2
|
[NCBI]
|
5.22193e-05
|
|
|
langerhans cell histiocytosis
|
[NCBI]
|
5.22193e-05
|
|
|
keratitis, hereditary
|
[NCBI]
|
5.22193e-05
|
|
|
LIMM
|
[NCBI]
|
5.22193e-05
|
|
|
malonyl-coa decarboxylase deficiency
|
[NCBI]
|
5.22193e-05
|
|
|
interleukin 2 receptor, alpha, deficiency of
|
[NCBI]
|
5.22193e-05
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
5.22193e-05
|
|
|
combined saposin deficiency
|
[NCBI]
|
5.22193e-05
|
|
|
mucopolysaccharidoses, unclassified types
|
[NCBI]
|
5.22193e-05
|
|
|
egasyn
|
[NCBI]
|
5.22193e-05
|
|
|
dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema
|
[NCBI]
|
5.22193e-05
|
|
|
lathosterolosis
|
[NCBI]
|
5.22193e-05
|
|
|
caroli disease, isolated
|
[NCBI]
|
5.22193e-05
|
|
|
hyperferritinemia-cataract syndrome
|
[NCBI]
|
5.22193e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
5.22193e-05
|
|
|
USH1F
|
[NCBI]
|
5.22193e-05
|
|
|
fumarase deficiency
|
[NCBI]
|
5.22193e-05
|
|
|
CMAH
|
[NCBI]
|
5.22193e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
5.21403e-05
|
|
|
CEBPB
|
[NCBI]
|
5.19317e-05
|
|
|
UPB1
|
[NCBI]
|
5.05575e-05
|
|
|
HMGCS1
|
[NCBI]
|
5.05575e-05
|
|
|
NAGS
|
[NCBI]
|
5.05575e-05
|
|
|
BAAT
|
[NCBI]
|
5.05575e-05
|
|
|
SLCO1B1
|
[NCBI]
|
5.05575e-05
|
|
|
ALDH1B1
|
[NCBI]
|
5.05575e-05
|
|
|
HAL
|
[NCBI]
|
5.05575e-05
|
|
|
UGT1A8
|
[NCBI]
|
5.05575e-05
|
|
|
perchloric acid-soluble protein, 14.5-kd
|
[NCBI]
|
5.05575e-05
|
|
|
alkaline phosphatase, intestinal, fetal form
|
[NCBI]
|
5.05575e-05
|
|
|
IRS2
|
[NCBI]
|
5.05171e-05
|
|
|
DGS
|
[NCBI]
|
4.97601e-05
|
|
|
ENPP1
|
[NCBI]
|
4.96234e-05
|
|
|
TG
|
[NCBI]
|
4.90127e-05
|
|
|
CDS
|
[NCBI]
|
4.89313e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
4.81931e-05
|
|
|
LBP
|
[NCBI]
|
4.81328e-05
|
|
|
APOM
|
[NCBI]
|
4.8051e-05
|
|
|
CYGB
|
[NCBI]
|
4.8051e-05
|
|
|
ABP1
|
[NCBI]
|
4.79347e-05
|
|
|
SRF
|
[NCBI]
|
4.7572e-05
|
|
|
BBS
|
[NCBI]
|
4.66349e-05
|
|
|
COMP
|
[NCBI]
|
4.65073e-05
|
|
|
CPB2
|
[NCBI]
|
4.65017e-05
|
|
|
WAS
|
[NCBI]
|
4.64589e-05
|
|
|
CGL2
|
[NCBI]
|
4.59759e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
4.59759e-05
|
|
|
SLSN1
|
[NCBI]
|
4.59759e-05
|
|
|
IPEX
|
[NCBI]
|
4.59759e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
4.59759e-05
|
|
|
PCSK9
|
[NCBI]
|
4.57342e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
4.53446e-05
|
|
|
C4B
|
[NCBI]
|
4.53446e-05
|
|
|
delta antigen-interacting protein a
|
[NCBI]
|
4.42764e-05
|
|
|
FGL1
|
[NCBI]
|
4.42764e-05
|
|
|
SLC38A4
|
[NCBI]
|
4.42764e-05
|
|
|
SUOX
|
[NCBI]
|
4.42764e-05
|
|
|
PEX11G
|
[NCBI]
|
4.42764e-05
|
|
|
UGT1A7
|
[NCBI]
|
4.42764e-05
|
|
|
C1S
|
[NCBI]
|
4.42764e-05
|
|
|
UGT1A6
|
[NCBI]
|
4.42764e-05
|
|
|
PFKFB4
|
[NCBI]
|
4.42764e-05
|
|
|
MTHFS
|
[NCBI]
|
4.42764e-05
|
|
|
FETUB
|
[NCBI]
|
4.42764e-05
|
|
|
UGT1A4
|
[NCBI]
|
4.42764e-05
|
|
|
PMVK
|
[NCBI]
|
4.42764e-05
|
|
|
EHHADH
|
[NCBI]
|
4.42764e-05
|
|
|
ALFN1
|
[NCBI]
|
4.42764e-05
|
|
|
PON1
|
[NCBI]
|
4.38756e-05
|
|
|
amyloidosis, familial visceral
|
[NCBI]
|
4.3299e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
4.3299e-05
|
|
|
PFIC2
|
[NCBI]
|
4.3299e-05
|
|
|
ichthyosiform erythroderma, corneal involvement, and deafness
|
[NCBI]
|
4.3299e-05
|
|
|
HFE3
|
[NCBI]
|
4.3299e-05
|
|
|
MKS3
|
[NCBI]
|
4.3299e-05
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
4.3299e-05
|
|
|
GRTH
|
[NCBI]
|
4.3299e-05
|
|
|
desmosterolosis
|
[NCBI]
|
4.3299e-05
|
|
|
3-@hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
4.3299e-05
|
|
|
acyl-coa dehydrogenase, long-chain, deficiency of
|
[NCBI]
|
4.3299e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
4.3299e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
4.3299e-05
|
|
|
achondroplasia, so-called, and severe combined immunodeficiency
|
[NCBI]
|
4.3299e-05
|
|
|
LSFC
|
[NCBI]
|
4.3299e-05
|
|
|
ORW2
|
[NCBI]
|
4.32431e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
4.32431e-05
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
4.32431e-05
|
|
|
ALDH9A1
|
[NCBI]
|
4.28633e-05
|
|
|
INSIG2
|
[NCBI]
|
4.28633e-05
|
|
|
SLC22A7
|
[NCBI]
|
4.28633e-05
|
|
|
NR1I3
|
[NCBI]
|
4.28633e-05
|
|
|
EIF2AK4
|
[NCBI]
|
4.28633e-05
|
|
|
GPD1
|
[NCBI]
|
4.28633e-05
|
|
|
ITIH3
|
[NCBI]
|
4.28633e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
4.24358e-05
|
|
|
MJD
|
[NCBI]
|
4.23026e-05
|
|
|
IDDM
|
[NCBI]
|
4.22217e-05
|
|
|
SULT1A3
|
[NCBI]
|
4.21324e-05
|
|
|
ABCB4
|
[NCBI]
|
4.21324e-05
|
|
|
AHSG
|
[NCBI]
|
4.21324e-05
|
|
|
FMO1
|
[NCBI]
|
4.21324e-05
|
|
|
GLDC
|
[NCBI]
|
4.21324e-05
|
|
|
homocystinuria
|
[NCBI]
|
4.1377e-05
|
|
|
HSD11B1
|
[NCBI]
|
4.06188e-05
|
|
|
PF4
|
[NCBI]
|
4.05865e-05
|
|
|
TS
|
[NCBI]
|
4.03672e-05
|
|
|
KLF1
|
[NCBI]
|
4.03634e-05
|
|
|
GAPDH
|
[NCBI]
|
4.00495e-05
|
|
|
FGF7
|
[NCBI]
|
3.98063e-05
|
|
|
NR1D1
|
[NCBI]
|
3.90151e-05
|
|
|
CYP7A1
|
[NCBI]
|
3.90151e-05
|
|
|
ONECUT1
|
[NCBI]
|
3.90151e-05
|
|
|
INSIG1
|
[NCBI]
|
3.90151e-05
|
|
|
NF1
|
[NCBI]
|
3.86091e-05
|
|
|
PIGR
|
[NCBI]
|
3.85571e-05
|
|
|
IDUA
|
[NCBI]
|
3.84184e-05
|
|
|
TGD
|
[NCBI]
|
3.83474e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
3.83474e-05
|
|
|
ABCG5
|
[NCBI]
|
3.74873e-05
|
|
|
ANGPTL3
|
[NCBI]
|
3.74873e-05
|
|
|
MPV17
|
[NCBI]
|
3.74873e-05
|
|
|
PRKAG1
|
[NCBI]
|
3.74873e-05
|
|
|
SULT2A1
|
[NCBI]
|
3.74873e-05
|
|
|
DPYS
|
[NCBI]
|
3.74873e-05
|
|
|
PHKG2
|
[NCBI]
|
3.74873e-05
|
|
|
MUC1
|
[NCBI]
|
3.71168e-05
|
|
|
h-y antigen receptor
|
[NCBI]
|
3.68473e-05
|
|
|
OPTB5
|
[NCBI]
|
3.68473e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
3.68473e-05
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
3.68473e-05
|
|
|
USH2C
|
[NCBI]
|
3.68473e-05
|
|
|
anemia, microcytic
|
[NCBI]
|
3.68473e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
3.68473e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
3.68473e-05
|
|
|
atransferrinemia
|
[NCBI]
|
3.68473e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
3.68473e-05
|
|
|
PDCD8
|
[NCBI]
|
3.67017e-05
|
|
|
HPX
|
[NCBI]
|
3.66064e-05
|
|
|
PTS
|
[NCBI]
|
3.62745e-05
|
|
|
CPT1A
|
[NCBI]
|
3.62745e-05
|
|
|
ALDH3A1
|
[NCBI]
|
3.62745e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
3.61451e-05
|
|
|
WBS
|
[NCBI]
|
3.60993e-05
|
|
|
GRP
|
[NCBI]
|
3.59086e-05
|
|
|
DCK
|
[NCBI]
|
3.56098e-05
|
|
|
MB
|
[NCBI]
|
3.54885e-05
|
|
|
FTL
|
[NCBI]
|
3.4813e-05
|
|
|
ADM
|
[NCBI]
|
3.43898e-05
|
|
|
MTR
|
[NCBI]
|
3.42008e-05
|
|
|
CML
|
[NCBI]
|
3.40849e-05
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
3.40849e-05
|
|
|
RETN
|
[NCBI]
|
3.38357e-05
|
|
|
NR1H3
|
[NCBI]
|
3.38357e-05
|
|
|
AGXT
|
[NCBI]
|
3.38357e-05
|
|
|
LRPAP1
|
[NCBI]
|
3.33524e-05
|
|
|
CYP1A2
|
[NCBI]
|
3.33524e-05
|
|
|
APOC3
|
[NCBI]
|
3.33524e-05
|
|
|
HMGCS2
|
[NCBI]
|
3.33524e-05
|
|
|
THRSP
|
[NCBI]
|
3.33524e-05
|
|
|
APOA1
|
[NCBI]
|
3.29038e-05
|
|
|
GTS
|
[NCBI]
|
3.20762e-05
|
|
|
menkes disease
|
[NCBI]
|
3.19453e-05
|
|
|
MODY3
|
[NCBI]
|
3.18495e-05
|
|
|
NPHP2
|
[NCBI]
|
3.18495e-05
|
|
|
xanthinuria, type i
|
[NCBI]
|
3.18495e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
3.18495e-05
|
|
|
autoimmune disease
|
[NCBI]
|
3.18495e-05
|
|
|
EPD
|
[NCBI]
|
3.18495e-05
|
|
|
FHL2
|
[NCBI]
|
3.18495e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
3.18495e-05
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
3.18495e-05
|
|
|
USH1D
|
[NCBI]
|
3.18495e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
3.18495e-05
|
|
|
cardiomyopathy, infantile histiocytoid
|
[NCBI]
|
3.18495e-05
|
|
|
EHBA
|
[NCBI]
|
3.18495e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
3.18495e-05
|
|
|
AQP9
|
[NCBI]
|
3.16441e-05
|
|
|
SAA1
|
[NCBI]
|
3.16441e-05
|
|
|
MFS
|
[NCBI]
|
3.15803e-05
|
|
|
PER1
|
[NCBI]
|
3.15738e-05
|
|
|
SPP2
|
[NCBI]
|
3.08654e-05
|
|
|
NKX2-8
|
[NCBI]
|
3.08654e-05
|
|
|
nitric oxide synthase, chondrocyte
|
[NCBI]
|
3.08654e-05
|
|
|
UGT1A9
|
[NCBI]
|
3.08654e-05
|
|
|
PON3
|
[NCBI]
|
3.08654e-05
|
|
|
AKR1D1
|
[NCBI]
|
3.08654e-05
|
|
|
SQLE
|
[NCBI]
|
3.08654e-05
|
|
|
PYGB
|
[NCBI]
|
3.08654e-05
|
|
|
AADAC
|
[NCBI]
|
3.08654e-05
|
|
|
ELOVL6
|
[NCBI]
|
3.08654e-05
|
|
|
PPP1R3B
|
[NCBI]
|
3.08654e-05
|
|
|
CYP8B1
|
[NCBI]
|
3.08654e-05
|
|
|
KYNU
|
[NCBI]
|
3.08654e-05
|
|
|
IDI1
|
[NCBI]
|
3.08654e-05
|
|
|
AKR7A2
|
[NCBI]
|
3.08654e-05
|
|
|
SULT1B1
|
[NCBI]
|
3.08654e-05
|
|
|
ARFIP1
|
[NCBI]
|
3.08654e-05
|
|
|
TMEM67
|
[NCBI]
|
3.08654e-05
|
|
|
MKS1
|
[NCBI]
|
3.08654e-05
|
|
|
MATR3
|
[NCBI]
|
3.08654e-05
|
|
|
UGT1A3
|
[NCBI]
|
3.08654e-05
|
|
|
ALD
|
[NCBI]
|
3.01675e-05
|
|
|
LECT2
|
[NCBI]
|
3.00049e-05
|
|
|
PROX1
|
[NCBI]
|
3.00049e-05
|
|
|
PRKAA2
|
[NCBI]
|
3.00049e-05
|
|
|
MLYCD
|
[NCBI]
|
3.00049e-05
|
|
|
PHYH
|
[NCBI]
|
3.00049e-05
|
|
|
ACACB
|
[NCBI]
|
3.00049e-05
|
|
|
methemoglobinemia due to deficiency of cytochrome b5
|
[NCBI]
|
3.00049e-05
|
|
|
OGT
|
[NCBI]
|
3.00049e-05
|
|
|
ED1
|
[NCBI]
|
2.97639e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
2.96686e-05
|
|
|
APP
|
[NCBI]
|
2.93974e-05
|
|
|
NAT1
|
[NCBI]
|
2.8722e-05
|
|
|
PCD
|
[NCBI]
|
2.864e-05
|
|
|
PMCH
|
[NCBI]
|
2.86022e-05
|
|
|
ARNT
|
[NCBI]
|
2.7969e-05
|
|
|
TPO
|
[NCBI]
|
2.79409e-05
|
|
|
PSAP
|
[NCBI]
|
2.78539e-05
|
|
|
APOC2
|
[NCBI]
|
2.78493e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
2.78124e-05
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
2.78124e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
2.78124e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
2.78124e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
2.78124e-05
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
2.78124e-05
|
|
|
ADHR
|
[NCBI]
|
2.78124e-05
|
|
|
APBD
|
[NCBI]
|
2.78124e-05
|
|
|
CMRD
|
[NCBI]
|
2.78124e-05
|
|
|
OMP
|
[NCBI]
|
2.76474e-05
|
|
|
FASN
|
[NCBI]
|
2.74186e-05
|
|
|
ARSB
|
[NCBI]
|
2.74186e-05
|
|
|
glutathionuria
|
[NCBI]
|
2.7205e-05
|
|
|
GYS1
|
[NCBI]
|
2.7205e-05
|
|
|
NR1H2
|
[NCBI]
|
2.7205e-05
|
|
|
DNASE2
|
[NCBI]
|
2.7205e-05
|
|
|
PKHD1
|
[NCBI]
|
2.7205e-05
|
|
|
TST
|
[NCBI]
|
2.7205e-05
|
|
|
AKT2
|
[NCBI]
|
2.7205e-05
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
2.7205e-05
|
|
|
INS
|
[NCBI]
|
2.69634e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
2.64546e-05
|
|
|
GFER
|
[NCBI]
|
2.61899e-05
|
|
|
IRS1
|
[NCBI]
|
2.53498e-05
|
|
|
CBX5
|
[NCBI]
|
2.53343e-05
|
|
|
CPT1B
|
[NCBI]
|
2.49908e-05
|
|
|
FGF21
|
[NCBI]
|
2.49908e-05
|
|
|
QPRT
|
[NCBI]
|
2.49908e-05
|
|
|
LSS
|
[NCBI]
|
2.49908e-05
|
|
|
GGT2
|
[NCBI]
|
2.49908e-05
|
|
|
HBQ1
|
[NCBI]
|
2.49908e-05
|
|
|
UGT1A10
|
[NCBI]
|
2.49908e-05
|
|
|
MAT2A
|
[NCBI]
|
2.49908e-05
|
|
|
HPN
|
[NCBI]
|
2.49908e-05
|
|
|
COX6A1
|
[NCBI]
|
2.49908e-05
|
|
|
GPAM
|
[NCBI]
|
2.49908e-05
|
|
|
ITIH2
|
[NCBI]
|
2.49908e-05
|
|
|
FMO5
|
[NCBI]
|
2.49908e-05
|
|
|
COX4I1
|
[NCBI]
|
2.49908e-05
|
|
|
ALAS1
|
[NCBI]
|
2.49908e-05
|
|
|
GSTZ1
|
[NCBI]
|
2.49908e-05
|
|
|
chitobiase, di-n-acetyl-
|
[NCBI]
|
2.49908e-05
|
|
|
fructosuria
|
[NCBI]
|
2.49908e-05
|
|
|
AK3L1
|
[NCBI]
|
2.49908e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.48282e-05
|
|
|
FGF19
|
[NCBI]
|
2.48091e-05
|
|
|
SLC17A5
|
[NCBI]
|
2.48091e-05
|
|
|
FMO3
|
[NCBI]
|
2.48091e-05
|
|
|
SULT1A1
|
[NCBI]
|
2.48091e-05
|
|
|
C5
|
[NCBI]
|
2.48091e-05
|
|
|
GPX4
|
[NCBI]
|
2.48091e-05
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
2.46611e-05
|
|
|
CTSB
|
[NCBI]
|
2.46611e-05
|
|
|
mast cell disease
|
[NCBI]
|
2.44582e-05
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
2.44582e-05
|
|
|
CDG2A
|
[NCBI]
|
2.44582e-05
|
|
|
mitochondrial complex ii deficiency
|
[NCBI]
|
2.44582e-05
|
|
|
DFNB3
|
[NCBI]
|
2.44582e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
2.44582e-05
|
|
|
IDE
|
[NCBI]
|
2.41365e-05
|
|
|
TNC
|
[NCBI]
|
2.33313e-05
|
|
|
HLF
|
[NCBI]
|
2.32469e-05
|
|
|
USF2
|
[NCBI]
|
2.32469e-05
|
|
|
DLD
|
[NCBI]
|
2.32469e-05
|
|
|
MAN2B1
|
[NCBI]
|
2.32469e-05
|
|
|
AT
|
[NCBI]
|
2.31345e-05
|
|
|
SCARB1
|
[NCBI]
|
2.27241e-05
|
|
|
ALPI
|
[NCBI]
|
2.27241e-05
|
|
|
MT1A
|
[NCBI]
|
2.27241e-05
|
|
|
CYP2C19
|
[NCBI]
|
2.27241e-05
|
|
|
HADH
|
[NCBI]
|
2.27241e-05
|
|
|
AIS
|
[NCBI]
|
2.24987e-05
|
|
|
AP1GBP1
|
[NCBI]
|
2.21378e-05
|
|
|
FNDC1
|
[NCBI]
|
2.21378e-05
|
|
|
DSCR4
|
[NCBI]
|
2.21378e-05
|
|
|
DNAJB4
|
[NCBI]
|
2.21378e-05
|
|
|
multidrug and toxin extrusion protein 2
|
[NCBI]
|
2.21378e-05
|
|
|
STARD6
|
[NCBI]
|
2.21378e-05
|
|
|
PSMA4
|
[NCBI]
|
2.21378e-05
|
|
|
PPP1R3D
|
[NCBI]
|
2.21378e-05
|
|
|
kiaa1324
|
[NCBI]
|
2.21378e-05
|
|
|
CYP4F12
|
[NCBI]
|
2.21378e-05
|
|
|
MYO1B
|
[NCBI]
|
2.21378e-05
|
|
|
UBE2S
|
[NCBI]
|
2.21378e-05
|
|
|
TMPRSS9
|
[NCBI]
|
2.21378e-05
|
|
|
UGT1A5
|
[NCBI]
|
2.21378e-05
|
|
|
BEX4
|
[NCBI]
|
2.21378e-05
|
|
|
multidrug and toxin extrusion protein 1
|
[NCBI]
|
2.21378e-05
|
|
|
SLC38A5
|
[NCBI]
|
2.21378e-05
|
|
|
ARHGAP28
|
[NCBI]
|
2.21378e-05
|
|
|
GCAT
|
[NCBI]
|
2.21378e-05
|
|
|
MIRN376A-1
|
[NCBI]
|
2.21378e-05
|
|
|
DGAT2
|
[NCBI]
|
2.21378e-05
|
|
|
TMEM159
|
[NCBI]
|
2.21378e-05
|
|
|
FBXO17
|
[NCBI]
|
2.21378e-05
|
|
|
GCHFR
|
[NCBI]
|
2.21378e-05
|
|
|
d-2-@hydroxyglutarate dehydrogenase
|
[NCBI]
|
2.21378e-05
|
|
|
TM4SF4
|
[NCBI]
|
2.21378e-05
|
|
|
MED9
|
[NCBI]
|
2.21378e-05
|
|
|
GPR45
|
[NCBI]
|
2.21378e-05
|
|
|
ZHX1
|
[NCBI]
|
2.21378e-05
|
|
|
OAZIN
|
[NCBI]
|
2.21378e-05
|
|
|
homeodomain leucine zipper-containing factor
|
[NCBI]
|
2.21378e-05
|
|
|
FRRS1
|
[NCBI]
|
2.21378e-05
|
|
|
HSD17B12
|
[NCBI]
|
2.21378e-05
|
|
|
VPS13C
|
[NCBI]
|
2.21378e-05
|
|
|
TCP10L
|
[NCBI]
|
2.21378e-05
|
|
|
STX18
|
[NCBI]
|
2.21378e-05
|
|
|
ADH6
|
[NCBI]
|
2.21378e-05
|
|
|
CCRN4L
|
[NCBI]
|
2.21378e-05
|
|
|
PECR
|
[NCBI]
|
2.21378e-05
|
|
|
FBXO27
|
[NCBI]
|
2.21378e-05
|
|
|
RND2
|
[NCBI]
|
2.21378e-05
|
|
|
TMPRSS6
|
[NCBI]
|
2.21378e-05
|
|
|
melanoma inhibitory activity protein 2
|
[NCBI]
|
2.21378e-05
|
|
|
BLOC1S2
|
[NCBI]
|
2.21378e-05
|
|
|
IFT80
|
[NCBI]
|
2.21378e-05
|
|
|
LEAP2
|
[NCBI]
|
2.21378e-05
|
|
|
APOC4
|
[NCBI]
|
2.21378e-05
|
|
|
CLK4
|
[NCBI]
|
2.21378e-05
|
|
|
KCNT1
|
[NCBI]
|
2.21378e-05
|
|
|
MED8
|
[NCBI]
|
2.21378e-05
|
|
|
DUX1
|
[NCBI]
|
2.21378e-05
|
|
|
ZHX2
|
[NCBI]
|
2.21378e-05
|
|
|
COLEC10
|
[NCBI]
|
2.21378e-05
|
|
|
KCNK13
|
[NCBI]
|
2.21378e-05
|
|
|
TRIM23
|
[NCBI]
|
2.21378e-05
|
|
|
ZAKI4
|
[NCBI]
|
2.21378e-05
|
|
|
HAO2
|
[NCBI]
|
2.21378e-05
|
|
|
tissue-specific extinguisher 3
|
[NCBI]
|
2.21378e-05
|
|
|
MIRN24-2
|
[NCBI]
|
2.21378e-05
|
|
|
NUP54
|
[NCBI]
|
2.21378e-05
|
|
|
MIRN199A1
|
[NCBI]
|
2.21378e-05
|
|
|
UGT2B10
|
[NCBI]
|
2.21378e-05
|
|
|
FBXO42
|
[NCBI]
|
2.21378e-05
|
|
|
SIPA1L2
|
[NCBI]
|
2.21378e-05
|
|
|
CYP4F2
|
[NCBI]
|
2.21378e-05
|
|
|
SDS
|
[NCBI]
|
2.21378e-05
|
|
|
TRMT5
|
[NCBI]
|
2.21378e-05
|
|
|
HACL1
|
[NCBI]
|
2.21378e-05
|
|
|
hepatocellular carcinoma-downregulated mitochondrial carrier protein
|
[NCBI]
|
2.21378e-05
|
|
|
CRYL1
|
[NCBI]
|
2.21378e-05
|
|
|
SLC35B1
|
[NCBI]
|
2.21378e-05
|
|
|
MON1A
|
[NCBI]
|
2.21378e-05
|
|
|
DUX2
|
[NCBI]
|
2.21378e-05
|
|
|
MVD
|
[NCBI]
|
2.21378e-05
|
|
|
COL27A1
|
[NCBI]
|
2.21378e-05
|
|
|
mitotic phosphoprotein 44
|
[NCBI]
|
2.21378e-05
|
|
|
SLC22A10
|
[NCBI]
|
2.21378e-05
|
|
|
nuclear protein p30
|
[NCBI]
|
2.21378e-05
|
|
|
ZNF367
|
[NCBI]
|
2.21378e-05
|
|
|
BEX5
|
[NCBI]
|
2.21378e-05
|
|
|
HIBADH
|
[NCBI]
|
2.21378e-05
|
|
|
TSPAN6
|
[NCBI]
|
2.21378e-05
|
|
|
MIRN376A-2
|
[NCBI]
|
2.21378e-05
|
|
|
C10ORF59
|
[NCBI]
|
2.21378e-05
|
|
|
IFI44
|
[NCBI]
|
2.21378e-05
|
|
|
PFKFB2
|
[NCBI]
|
2.21378e-05
|
|
|
DUX3
|
[NCBI]
|
2.21378e-05
|
|
|
ONECUT2
|
[NCBI]
|
2.21378e-05
|
|
|
STARD4
|
[NCBI]
|
2.21378e-05
|
|
|
NDUFA4
|
[NCBI]
|
2.21378e-05
|
|
|
DUX5
|
[NCBI]
|
2.21378e-05
|
|
|
MIRN368
|
[NCBI]
|
2.21378e-05
|
|
|
hepatocellular carcinoma complicating hemochromatosis
|
[NCBI]
|
2.21378e-05
|
|
|
TSE2
|
[NCBI]
|
2.21378e-05
|
|
|
SLC25A31
|
[NCBI]
|
2.21378e-05
|
|
|
NANP
|
[NCBI]
|
2.21378e-05
|
|
|
FTHFD
|
[NCBI]
|
2.21378e-05
|
|
|
PHPT1
|
[NCBI]
|
2.21378e-05
|
|
|
SPIRE2
|
[NCBI]
|
2.21378e-05
|
|
|
SCLY
|
[NCBI]
|
2.21378e-05
|
|
|
RPLP0
|
[NCBI]
|
2.21378e-05
|
|
|
LIN28B
|
[NCBI]
|
2.21378e-05
|
|
|
LIPI
|
[NCBI]
|
2.21378e-05
|
|
|
STARD5
|
[NCBI]
|
2.21378e-05
|
|
|
MIRN376B
|
[NCBI]
|
2.21378e-05
|
|
|
MIRN199A2
|
[NCBI]
|
2.21378e-05
|
|
|
BCR
|
[NCBI]
|
2.21171e-05
|
|
|
TGM2
|
[NCBI]
|
2.19339e-05
|
|
|
RPS6
|
[NCBI]
|
2.19339e-05
|
|
|
IFNA1
|
[NCBI]
|
2.19335e-05
|
|
|
fucosidosis
|
[NCBI]
|
2.18722e-05
|
|
|
GBD1
|
[NCBI]
|
2.16145e-05
|
|
|
MODY1
|
[NCBI]
|
2.16145e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
2.16145e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
2.16145e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
2.16145e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
2.16145e-05
|
|
|
IVA
|
[NCBI]
|
2.16145e-05
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
2.16145e-05
|
|
|
FMR1
|
[NCBI]
|
2.14816e-05
|
|
|
PRKAB1
|
[NCBI]
|
2.10649e-05
|
|
|
AKR1C3
|
[NCBI]
|
2.10649e-05
|
|
|
ACLY
|
[NCBI]
|
2.10649e-05
|
|
|
AOX1
|
[NCBI]
|
2.10649e-05
|
|
|
ABAT
|
[NCBI]
|
2.10649e-05
|
|
|
FMO4
|
[NCBI]
|
2.10649e-05
|
|
|
STE
|
[NCBI]
|
2.10649e-05
|
|
|
HCF2
|
[NCBI]
|
2.10649e-05
|
|
|
GPX2
|
[NCBI]
|
2.10649e-05
|
|
|
vesicle docking protein, 115-kd
|
[NCBI]
|
2.10649e-05
|
|
|
RORB
|
[NCBI]
|
2.10649e-05
|
|
|
SEC13L1
|
[NCBI]
|
2.10649e-05
|
|
|
SEPS1
|
[NCBI]
|
2.10649e-05
|
|
|
SLC27A2
|
[NCBI]
|
2.10649e-05
|
|
|
GNS
|
[NCBI]
|
2.10649e-05
|
|
|
LMF1
|
[NCBI]
|
2.10649e-05
|
|
|
ADH4
|
[NCBI]
|
2.10649e-05
|
|
|
HK3
|
[NCBI]
|
2.10649e-05
|
|
|
RB1
|
[NCBI]
|
2.09782e-05
|
|
|
NGFR
|
[NCBI]
|
2.09782e-05
|
|
|
APCS
|
[NCBI]
|
2.09234e-05
|
|
|
GAMT
|
[NCBI]
|
2.09234e-05
|
|
|
BMI1
|
[NCBI]
|
2.08861e-05
|
|
|
CLEC4M
|
[NCBI]
|
2.08861e-05
|
|
|
XBP1
|
[NCBI]
|
2.08861e-05
|
|
|
CPS1
|
[NCBI]
|
2.08861e-05
|
|
|
HHEX
|
[NCBI]
|
2.08861e-05
|
|
|
GSTP1
|
[NCBI]
|
2.07111e-05
|
|
|
CYP2A6
|
[NCBI]
|
2.07111e-05
|
|
|
EEF2
|
[NCBI]
|
2.07111e-05
|
|
|
KSS
|
[NCBI]
|
2.02321e-05
|
|
|
EPO
|
[NCBI]
|
1.9744e-05
|
|
|
SI
|
[NCBI]
|
1.96712e-05
|
|
|
APRT
|
[NCBI]
|
1.93495e-05
|
|
|
PPARG
|
[NCBI]
|
1.93167e-05
|
|
|
AKR1A1
|
[NCBI]
|
1.92492e-05
|
|
|
AMY1A
|
[NCBI]
|
1.92492e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
1.91671e-05
|
|
|
USH3
|
[NCBI]
|
1.91671e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
1.90728e-05
|
|
|
PRKCM
|
[NCBI]
|
1.88391e-05
|
|
|
FGFR1
|
[NCBI]
|
1.85628e-05
|
|
|
HDAC1
|
[NCBI]
|
1.82872e-05
|
|
|
MCP
|
[NCBI]
|
1.82516e-05
|
|
|
BAG1
|
[NCBI]
|
1.8136e-05
|
|
|
SH2B1
|
[NCBI]
|
1.8136e-05
|
|
|
GPX3
|
[NCBI]
|
1.8136e-05
|
|
|
ATOX1
|
[NCBI]
|
1.8136e-05
|
|
|
SPTBN1
|
[NCBI]
|
1.8136e-05
|
|
|
PSCD1
|
[NCBI]
|
1.8136e-05
|
|
|
NFE2L1
|
[NCBI]
|
1.8136e-05
|
|
|
ACOT7
|
[NCBI]
|
1.8136e-05
|
|
|
AADAT
|
[NCBI]
|
1.8136e-05
|
|
|
ENO3
|
[NCBI]
|
1.8136e-05
|
|
|
ITIH1
|
[NCBI]
|
1.8136e-05
|
|
|
ME1
|
[NCBI]
|
1.8136e-05
|
|
|
PCTP
|
[NCBI]
|
1.8136e-05
|
|
|
ABCC6
|
[NCBI]
|
1.74969e-05
|
|
|
CASR
|
[NCBI]
|
1.7464e-05
|
|
|
PRLR
|
[NCBI]
|
1.7455e-05
|
|
|
DBI
|
[NCBI]
|
1.73314e-05
|
|
|
ABCC8
|
[NCBI]
|
1.71908e-05
|
|
|
canavan disease
|
[NCBI]
|
1.70363e-05
|
|
|
HMBS
|
[NCBI]
|
1.70141e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.67684e-05
|
|
|
TNFSF10
|
[NCBI]
|
1.65431e-05
|
|
|
G6PT1
|
[NCBI]
|
1.64497e-05
|
|
|
DBT
|
[NCBI]
|
1.64497e-05
|
|
|
PER2
|
[NCBI]
|
1.64497e-05
|
|
|
MAPK1
|
[NCBI]
|
1.63753e-05
|
|
|
NPM1
|
[NCBI]
|
1.63753e-05
|
|
|
AKR1B1
|
[NCBI]
|
1.61786e-05
|
|
|
SOD1
|
[NCBI]
|
1.61692e-05
|
|
|
PTEN
|
[NCBI]
|
1.5835e-05
|
|
|
PTPRF
|
[NCBI]
|
1.58209e-05
|
|
|
PCK2
|
[NCBI]
|
1.58209e-05
|
|
|
PHKB
|
[NCBI]
|
1.58209e-05
|
|
|
CRTC2
|
[NCBI]
|
1.58209e-05
|
|
|
AMBP
|
[NCBI]
|
1.58209e-05
|
|
|
GBE1
|
[NCBI]
|
1.58209e-05
|
|
|
IRF2
|
[NCBI]
|
1.58209e-05
|
|
|
LHX2
|
[NCBI]
|
1.58209e-05
|
|
|
AVPR1A
|
[NCBI]
|
1.58209e-05
|
|
|
ORM1
|
[NCBI]
|
1.58209e-05
|
|
|
PCBD1
|
[NCBI]
|
1.58209e-05
|
|
|
NDST2
|
[NCBI]
|
1.58209e-05
|
|
|
MYST3
|
[NCBI]
|
1.58209e-05
|
|
|
BTD
|
[NCBI]
|
1.58209e-05
|
|
|
FGA
|
[NCBI]
|
1.56657e-05
|
|
|
BGLAP
|
[NCBI]
|
1.56039e-05
|
|
|
ACE
|
[NCBI]
|
1.5364e-05
|
|
|
FTH1
|
[NCBI]
|
1.52407e-05
|
|
|
PPARBP
|
[NCBI]
|
1.52407e-05
|
|
|
ALDOA
|
[NCBI]
|
1.52407e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
1.51643e-05
|
|
|
USH1C
|
[NCBI]
|
1.51643e-05
|
|
|
HSAN2
|
[NCBI]
|
1.51643e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
1.51643e-05
|
|
|
omenn syndrome
|
[NCBI]
|
1.51643e-05
|
|
|
polycythemia vera
|
[NCBI]
|
1.51643e-05
|
|
|
DMD
|
[NCBI]
|
1.51319e-05
|
|
|
galactosemia
|
[NCBI]
|
1.50216e-05
|
|
|
ILK
|
[NCBI]
|
1.49655e-05
|
|
|
ABCC1
|
[NCBI]
|
1.49002e-05
|
|
|
HPRT1
|
[NCBI]
|
1.47632e-05
|
|
|
RHO
|
[NCBI]
|
1.44971e-05
|
|
|
ESD
|
[NCBI]
|
1.44971e-05
|
|
|
RASA1
|
[NCBI]
|
1.43986e-05
|
|
|
CVID
|
[NCBI]
|
1.42402e-05
|
|
|
SLC22A8
|
[NCBI]
|
1.41359e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.41319e-05
|
|
|
A2M
|
[NCBI]
|
1.40366e-05
|
|
|
JAG1
|
[NCBI]
|
1.40366e-05
|
|
|
H19
|
[NCBI]
|
1.40366e-05
|
|
|
AGER
|
[NCBI]
|
1.39659e-05
|
|
|
PPP1CA
|
[NCBI]
|
1.39236e-05
|
|
|
ADORA2A
|
[NCBI]
|
1.39236e-05
|
|
|
FOXA1
|
[NCBI]
|
1.39236e-05
|
|
|
MTHFD1
|
[NCBI]
|
1.39236e-05
|
|
|
PFKP
|
[NCBI]
|
1.39236e-05
|
|
|
APOBEC1
|
[NCBI]
|
1.39236e-05
|
|
|
FUT6
|
[NCBI]
|
1.39236e-05
|
|
|
SREBF2
|
[NCBI]
|
1.39236e-05
|
|
|
SLC18A3
|
[NCBI]
|
1.35935e-05
|
|
|
CLN2
|
[NCBI]
|
1.35077e-05
|
|
|
SMA2
|
[NCBI]
|
1.35077e-05
|
|
|
LCA1
|
[NCBI]
|
1.35077e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
1.35077e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
1.35077e-05
|
|
|
TERT
|
[NCBI]
|
1.35053e-05
|
|
|
MET
|
[NCBI]
|
1.32882e-05
|
|
|
SRC
|
[NCBI]
|
1.26579e-05
|
|
|
HDGF
|
[NCBI]
|
1.25796e-05
|
|
|
IKBKG
|
[NCBI]
|
1.25796e-05
|
|
|
SIRT1
|
[NCBI]
|
1.25796e-05
|
|
|
SLC25A10
|
[NCBI]
|
1.24951e-05
|
|
|
chondroitin sulfate glucuronyltransferase
|
[NCBI]
|
1.24951e-05
|
|
|
IGSF9
|
[NCBI]
|
1.24951e-05
|
|
|
WNT2B
|
[NCBI]
|
1.24951e-05
|
|
|
LIPB
|
[NCBI]
|
1.24951e-05
|
|
|
CYP2A13
|
[NCBI]
|
1.24951e-05
|
|
|
PTCHD2
|
[NCBI]
|
1.24951e-05
|
|
|
SCAMP3
|
[NCBI]
|
1.24951e-05
|
|
|
INTS1
|
[NCBI]
|
1.24951e-05
|
|
|
RPS15
|
[NCBI]
|
1.24951e-05
|
|
|
COX8
|
[NCBI]
|
1.24951e-05
|
|
|
TDO2
|
[NCBI]
|
1.24951e-05
|
|
|
PDCL
|
[NCBI]
|
1.24951e-05
|
|
|
pseudoautosomal gene xe7
|
[NCBI]
|
1.24951e-05
|
|
|
PLCD3
|
[NCBI]
|
1.24951e-05
|
|
|
ZNF333
|
[NCBI]
|
1.24951e-05
|
|
|
FABP1
|
[NCBI]
|
1.24951e-05
|
|
|
PSMA2
|
[NCBI]
|
1.24951e-05
|
|
|
CIP150
|
[NCBI]
|
1.24951e-05
|
|
|
RHBG
|
[NCBI]
|
1.24951e-05
|
|
|
RPN1
|
[NCBI]
|
1.24951e-05
|
|
|
SH3GLB2
|
[NCBI]
|
1.24951e-05
|
|
|
SYT13
|
[NCBI]
|
1.24951e-05
|
|
|
TBC1D20
|
[NCBI]
|
1.24951e-05
|
|
|
TSR1
|
[NCBI]
|
1.24951e-05
|
|
|
ABCC13
|
[NCBI]
|
1.24951e-05
|
|
|
ARID5A
|
[NCBI]
|
1.24951e-05
|
|
|
CTH
|
[NCBI]
|
1.24951e-05
|
|
|
ets transcription factor tel2
|
[NCBI]
|
1.24951e-05
|
|
|
AASS
|
[NCBI]
|
1.24951e-05
|
|
|
ACAA2
|
[NCBI]
|
1.24951e-05
|
|
|
rap gtpase interactor
|
[NCBI]
|
1.24951e-05
|
|
|
HYDIN2
|
[NCBI]
|
1.24951e-05
|
|
|
KLHL13
|
[NCBI]
|
1.24951e-05
|
|
|
SLC13A5
|
[NCBI]
|
1.24951e-05
|
|
|
PROZ
|
[NCBI]
|
1.24951e-05
|
|
|
PPP1R7
|
[NCBI]
|
1.24951e-05
|
|
|
HSPA14
|
[NCBI]
|
1.24951e-05
|
|
|
SEMA6C
|
[NCBI]
|
1.24951e-05
|
|
|
DOK5
|
[NCBI]
|
1.24951e-05
|
|
|
SYNJ2BP
|
[NCBI]
|
1.24951e-05
|
|
|
PNPO
|
[NCBI]
|
1.24951e-05
|
|
|
alkaline phosphatase, elevated serum
|
[NCBI]
|
1.24951e-05
|
|
|
PPP1R3C
|
[NCBI]
|
1.24951e-05
|
|
|
LZTS2
|
[NCBI]
|
1.24951e-05
|
|
|
GNG5
|
[NCBI]
|
1.24951e-05
|
|
|
GLYCTK
|
[NCBI]
|
1.24951e-05
|
|
|
C5ORF13
|
[NCBI]
|
1.24951e-05
|
|
|
OIT3
|
[NCBI]
|
1.24951e-05
|
|
|
SAA4
|
[NCBI]
|
1.24951e-05
|
|
|
MMAA
|
[NCBI]
|
1.24951e-05
|
|
|
GPSN2
|
[NCBI]
|
1.24951e-05
|
|
|
GDI2
|
[NCBI]
|
1.24951e-05
|
|
|
SLC38A2
|
[NCBI]
|
1.24951e-05
|
|
|
SNAPAP
|
[NCBI]
|
1.24951e-05
|
|
|
SLC13A1
|
[NCBI]
|
1.24951e-05
|
|
|
PTPLA
|
[NCBI]
|
1.24951e-05
|
|
|
early b-cell factor 4
|
[NCBI]
|
1.24951e-05
|
|
|
ash1, drosophila, homolog of
|
[NCBI]
|
1.24951e-05
|
|
|
SEPP1
|
[NCBI]
|
1.24951e-05
|
|
|
CYP3A43
|
[NCBI]
|
1.24951e-05
|
|
|
XE7Y
|
[NCBI]
|
1.24951e-05
|
|
|
CLDN2
|
[NCBI]
|
1.24951e-05
|
|
|
PRPSAP1
|
[NCBI]
|
1.24951e-05
|
|
|
MARCH4
|
[NCBI]
|
1.24951e-05
|
|
|
FBXO44
|
[NCBI]
|
1.24951e-05
|
|
|
lipin 3
|
[NCBI]
|
1.24951e-05
|
|
|
OSBPL6
|
[NCBI]
|
1.24951e-05
|
|
|
DOK4
|
[NCBI]
|
1.24951e-05
|
|
|
DOT1L
|
[NCBI]
|
1.24951e-05
|
|
|
AKR7A3
|
[NCBI]
|
1.24951e-05
|
|
|
GPBAR1
|
[NCBI]
|
1.24951e-05
|
|
|
PCDH10
|
[NCBI]
|
1.24951e-05
|
|
|
MASP2
|
[NCBI]
|
1.24951e-05
|
|
|
ARL5
|
[NCBI]
|
1.24951e-05
|
|
|
BRSK1
|
[NCBI]
|
1.24951e-05
|
|
|
VPS36
|
[NCBI]
|
1.24951e-05
|
|
|
TLOC1
|
[NCBI]
|
1.24951e-05
|
|
|
NUDT3
|
[NCBI]
|
1.24951e-05
|
|
|
flavoprotein oxidoreductase mical3
|
[NCBI]
|
1.24951e-05
|
|
|
RGL1
|
[NCBI]
|
1.24951e-05
|
|
|
SFRS8
|
[NCBI]
|
1.24951e-05
|
|
|
ERP29
|
[NCBI]
|
1.24951e-05
|
|
|
UGT2B11
|
[NCBI]
|
1.24951e-05
|
|
|
SULT1A2
|
[NCBI]
|
1.24951e-05
|
|
|
MMSDH
|
[NCBI]
|
1.24951e-05
|
|
|
CUTL2
|
[NCBI]
|
1.24951e-05
|
|
|
MYO7B
|
[NCBI]
|
1.24951e-05
|
|
|
SMPD4
|
[NCBI]
|
1.24951e-05
|
|
|
NAT8
|
[NCBI]
|
1.24951e-05
|
|
|
ARFGAP1
|
[NCBI]
|
1.24951e-05
|
|
|
MMP19
|
[NCBI]
|
1.24951e-05
|
|
|
SPG11
|
[NCBI]
|
1.24951e-05
|
|
|
KLHL9
|
[NCBI]
|
1.24951e-05
|
|
|
CHK
|
[NCBI]
|
1.24951e-05
|
|
|
FBXO6
|
[NCBI]
|
1.24951e-05
|
|
|
SEH1L
|
[NCBI]
|
1.24951e-05
|
|
|
MAN1A1
|
[NCBI]
|
1.24951e-05
|
|
|
ZNF687
|
[NCBI]
|
1.24951e-05
|
|
|
SFRS5
|
[NCBI]
|
1.24951e-05
|
|
|
SMEK2
|
[NCBI]
|
1.24951e-05
|
|
|
ABCB6
|
[NCBI]
|
1.24951e-05
|
|
|
SRGAP1
|
[NCBI]
|
1.24951e-05
|
|
|
kiaa1815
|
[NCBI]
|
1.24951e-05
|
|
|
NPL
|
[NCBI]
|
1.24951e-05
|
|
|
STK16
|
[NCBI]
|
1.24951e-05
|
|
|
RPAP1
|
[NCBI]
|
1.24951e-05
|
|
|
HSD3B7
|
[NCBI]
|
1.24951e-05
|
|
|
MIRN122A
|
[NCBI]
|
1.24951e-05
|
|
|
ODZ4
|
[NCBI]
|
1.24951e-05
|
|
|
HNF4G
|
[NCBI]
|
1.24951e-05
|
|
|
SLCO1A2
|
[NCBI]
|
1.24951e-05
|
|
|
PCDH19
|
[NCBI]
|
1.24951e-05
|
|
|
fmrp-interacting protein, 82-kd
|
[NCBI]
|
1.24951e-05
|
|
|
MOGAT1
|
[NCBI]
|
1.24951e-05
|
|
|
selenophosphate synthetase 1
|
[NCBI]
|
1.24951e-05
|
|
|
BEX2
|
[NCBI]
|
1.24951e-05
|
|
|
RPS28
|
[NCBI]
|
1.24951e-05
|
|
|
BAGE
|
[NCBI]
|
1.24951e-05
|
|
|
MARK4
|
[NCBI]
|
1.24951e-05
|
|
|
BLOC1S3
|
[NCBI]
|
1.24951e-05
|
|
|
NUP37
|
[NCBI]
|
1.24951e-05
|
|
|
ACOT2
|
[NCBI]
|
1.24951e-05
|
|
|
PAQR7
|
[NCBI]
|
1.24951e-05
|
|
|
RARS1
|
[NCBI]
|
1.24951e-05
|
|
|
SNF8
|
[NCBI]
|
1.24951e-05
|
|
|
ATP5I
|
[NCBI]
|
1.24951e-05
|
|
|
PPP1R8
|
[NCBI]
|
1.24951e-05
|
|
|
KCNK12
|
[NCBI]
|
1.24951e-05
|
|
|
NUP43
|
[NCBI]
|
1.24951e-05
|
|
|
NLGN2
|
[NCBI]
|
1.24951e-05
|
|
|
DUSP10
|
[NCBI]
|
1.24951e-05
|
|
|
FBN3
|
[NCBI]
|
1.24951e-05
|
|
|
COX7A2
|
[NCBI]
|
1.24951e-05
|
|
|
EPHA1
|
[NCBI]
|
1.24951e-05
|
|
|
SULT1C2
|
[NCBI]
|
1.24951e-05
|
|
|
MIRN24-1
|
[NCBI]
|
1.24951e-05
|
|
|
hurler syndrome
|
[NCBI]
|
1.24814e-05
|
|
|
FOXF1
|
[NCBI]
|
1.23295e-05
|
|
|
GCKR
|
[NCBI]
|
1.23295e-05
|
|
|
SAA2
|
[NCBI]
|
1.23295e-05
|
|
|
MBTPS1
|
[NCBI]
|
1.23295e-05
|
|
|
PEX6
|
[NCBI]
|
1.23295e-05
|
|
|
FGG
|
[NCBI]
|
1.23295e-05
|
|
|
PNKP
|
[NCBI]
|
1.23295e-05
|
|
|
FKHL16
|
[NCBI]
|
1.23295e-05
|
|
|
TTC10
|
[NCBI]
|
1.23295e-05
|
|
|
BCHE
|
[NCBI]
|
1.22587e-05
|
|
|
EPHX1
|
[NCBI]
|
1.21883e-05
|
|
|
LAMP2
|
[NCBI]
|
1.21883e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
1.21883e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.21404e-05
|
|
|
GPI
|
[NCBI]
|
1.20712e-05
|
|
|
SST
|
[NCBI]
|
1.20712e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
1.20334e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
1.20334e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
1.20334e-05
|
|
|
VED
|
[NCBI]
|
1.20334e-05
|
|
|
USH2A
|
[NCBI]
|
1.20334e-05
|
|
|
ALMS
|
[NCBI]
|
1.20334e-05
|
|
|
PTK2B
|
[NCBI]
|
1.1883e-05
|
|
|
ATM
|
[NCBI]
|
1.16267e-05
|
|
|
OPRM1
|
[NCBI]
|
1.13714e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.13258e-05
|
|
|
ARNTL
|
[NCBI]
|
1.13258e-05
|
|
|
HDC
|
[NCBI]
|
1.10571e-05
|
|
|
KRT18
|
[NCBI]
|
1.0966e-05
|
|
|
FBLN1
|
[NCBI]
|
1.0966e-05
|
|
|
HABP2
|
[NCBI]
|
1.0966e-05
|
|
|
FBXO32
|
[NCBI]
|
1.0966e-05
|
|
|
CEP290
|
[NCBI]
|
1.0966e-05
|
|
|
NOV
|
[NCBI]
|
1.0966e-05
|
|
|
RORA
|
[NCBI]
|
1.0966e-05
|
|
|
GBA
|
[NCBI]
|
1.07829e-05
|
|
|
PPSH
|
[NCBI]
|
1.07151e-05
|
|
|
SMA3
|
[NCBI]
|
1.07151e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
1.07151e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
1.07151e-05
|
|
|
ABCA1
|
[NCBI]
|
1.06656e-05
|
|
|
LPO
|
[NCBI]
|
1.03607e-05
|
|
|
SOD2
|
[NCBI]
|
1.02942e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
1.02536e-05
|
|
|
FGF2
|
[NCBI]
|
1.02415e-05
|
|
|
PLG
|
[NCBI]
|
1.01901e-05
|
|
|
PAM
|
[NCBI]
|
1.01696e-05
|
|
|
CRIP1
|
[NCBI]
|
9.78527e-06
|
|
|
IGF2R
|
[NCBI]
|
9.78527e-06
|
|
|
SORD
|
[NCBI]
|
9.78367e-06
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
9.78367e-06
|
|
|
LYZ
|
[NCBI]
|
9.78367e-06
|
|
|
HSD17B10
|
[NCBI]
|
9.78367e-06
|
|
|
KRT8
|
[NCBI]
|
9.78367e-06
|
|
|
MPO
|
[NCBI]
|
9.54257e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
9.53217e-06
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
9.53217e-06
|
|
|
FTNS
|
[NCBI]
|
9.53217e-06
|
|
|
ZFP36
|
[NCBI]
|
9.36833e-06
|
|
|
MVP
|
[NCBI]
|
9.12331e-06
|
|
|
CCND1
|
[NCBI]
|
9.12331e-06
|
|
|
PLAUR
|
[NCBI]
|
9.11023e-06
|
|
|
AGT
|
[NCBI]
|
9.09538e-06
|
|
|
THRA
|
[NCBI]
|
9.09538e-06
|
|
|
CPD
|
[NCBI]
|
9.09538e-06
|
|
|
DDOST
|
[NCBI]
|
9.09538e-06
|
|
|
CRYZ
|
[NCBI]
|
9.06772e-06
|
|
|
MAL2
|
[NCBI]
|
9.06772e-06
|
|
|
PIGF
|
[NCBI]
|
9.06772e-06
|
|
|
PEX11A
|
[NCBI]
|
9.06772e-06
|
|
|
SCO1
|
[NCBI]
|
9.06772e-06
|
|
|
SULT1C1
|
[NCBI]
|
9.06772e-06
|
|
|
CYP7B1
|
[NCBI]
|
9.06772e-06
|
|
|
EXOSC3
|
[NCBI]
|
9.06772e-06
|
|
|
SLC15A1
|
[NCBI]
|
9.06772e-06
|
|
|
RPS27A
|
[NCBI]
|
9.06772e-06
|
|
|
ARHGAP20
|
[NCBI]
|
9.06772e-06
|
|
|
HAAO
|
[NCBI]
|
9.06772e-06
|
|
|
MYT2
|
[NCBI]
|
9.06772e-06
|
|
|
UBA52
|
[NCBI]
|
9.06772e-06
|
|
|
MYO1F
|
[NCBI]
|
9.06772e-06
|
|
|
OSBPL1A
|
[NCBI]
|
9.06772e-06
|
|
|
MTIF2
|
[NCBI]
|
9.06772e-06
|
|
|
SLC25A25
|
[NCBI]
|
9.06772e-06
|
|
|
DUSP19
|
[NCBI]
|
9.06772e-06
|
|
|
CHD7
|
[NCBI]
|
9.06772e-06
|
|
|
SLC22A18AS
|
[NCBI]
|
9.06772e-06
|
|
|
PDHB
|
[NCBI]
|
9.06772e-06
|
|
|
FANCI
|
[NCBI]
|
9.06772e-06
|
|
|
NAV2
|
[NCBI]
|
9.06772e-06
|
|
|
GNG2
|
[NCBI]
|
9.06772e-06
|
|
|
HACE1
|
[NCBI]
|
9.06772e-06
|
|
|
nnx3 protein
|
[NCBI]
|
9.06772e-06
|
|
|
CFHR1
|
[NCBI]
|
9.06772e-06
|
|
|
AS3MT
|
[NCBI]
|
9.06772e-06
|
|
|
INHBC
|
[NCBI]
|
9.06772e-06
|
|
|
DPP3
|
[NCBI]
|
9.06772e-06
|
|
|
LCOR
|
[NCBI]
|
9.06772e-06
|
|
|
RETNLB
|
[NCBI]
|
9.06772e-06
|
|
|
RND1
|
[NCBI]
|
9.06772e-06
|
|
|
ACOX2
|
[NCBI]
|
9.06772e-06
|
|
|
PGLYRP2
|
[NCBI]
|
9.06772e-06
|
|
|
CLDN5
|
[NCBI]
|
9.06772e-06
|
|
|
VSIG4
|
[NCBI]
|
9.06772e-06
|
|
|
CLPS
|
[NCBI]
|
9.06772e-06
|
|
|
BLVRB
|
[NCBI]
|
9.06772e-06
|
|
|
CYB561
|
[NCBI]
|
9.06772e-06
|
|
|
TAOK1
|
[NCBI]
|
9.06772e-06
|
|
|
ETHE1
|
[NCBI]
|
9.06772e-06
|
|
|
HPR
|
[NCBI]
|
9.06772e-06
|
|
|
MAML3
|
[NCBI]
|
9.06772e-06
|
|
|
SIGLEC8
|
[NCBI]
|
9.06772e-06
|
|
|
VPS25
|
[NCBI]
|
9.06772e-06
|
|
|
CYP46A1
|
[NCBI]
|
9.06772e-06
|
|
|
GPLD1
|
[NCBI]
|
9.06772e-06
|
|
|
LGALS8
|
[NCBI]
|
9.06772e-06
|
|
|
BCL9
|
[NCBI]
|
9.06772e-06
|
|
|
nephrin-like 2
|
[NCBI]
|
9.06772e-06
|
|
|
UPP1
|
[NCBI]
|
9.06772e-06
|
|
|
MANBA
|
[NCBI]
|
9.06772e-06
|
|
|
RDBP
|
[NCBI]
|
9.06772e-06
|
|
|
SLCO1B3
|
[NCBI]
|
9.06772e-06
|
|
|
NPC1L1
|
[NCBI]
|
9.06772e-06
|
|
|
UBC
|
[NCBI]
|
9.06772e-06
|
|
|
FXYD5
|
[NCBI]
|
9.06772e-06
|
|
|
C7
|
[NCBI]
|
9.06772e-06
|
|
|
GPR39
|
[NCBI]
|
9.06772e-06
|
|
|
C1QDC1
|
[NCBI]
|
9.06772e-06
|
|
|
GDF2
|
[NCBI]
|
9.06772e-06
|
|
|
DTX1
|
[NCBI]
|
9.06772e-06
|
|
|
FABP6
|
[NCBI]
|
9.06772e-06
|
|
|
GSTM5
|
[NCBI]
|
9.06772e-06
|
|
|
TUFM
|
[NCBI]
|
9.06772e-06
|
|
|
WNT5B
|
[NCBI]
|
9.06772e-06
|
|
|
CYC1
|
[NCBI]
|
9.06772e-06
|
|
|
SLC35A2
|
[NCBI]
|
9.06772e-06
|
|
|
COLEC12
|
[NCBI]
|
9.06772e-06
|
|
|
CAND1
|
[NCBI]
|
9.06772e-06
|
|
|
PKN2
|
[NCBI]
|
9.06772e-06
|
|
|
NFYC
|
[NCBI]
|
9.06772e-06
|
|
|
TRAM2
|
[NCBI]
|
9.06772e-06
|
|
|
dnase2-like acid dnase
|
[NCBI]
|
9.06772e-06
|
|
|
IGBP1
|
[NCBI]
|
9.06772e-06
|
|
|
ANAPC2
|
[NCBI]
|
9.06772e-06
|
|
|
IKZF4
|
[NCBI]
|
9.06772e-06
|
|
|
EPHB4
|
[NCBI]
|
9.06772e-06
|
|
|
CPSF2
|
[NCBI]
|
9.06772e-06
|
|
|
FXYD2
|
[NCBI]
|
9.06772e-06
|
|
|
MTL5
|
[NCBI]
|
9.06772e-06
|
|
|
DECR1
|
[NCBI]
|
9.06772e-06
|
|
|
OSBPL3
|
[NCBI]
|
9.06772e-06
|
|
|
ST6GAL2
|
[NCBI]
|
9.06772e-06
|
|
|
ORM2
|
[NCBI]
|
9.06772e-06
|
|
|
kiaa1333
|
[NCBI]
|
9.06772e-06
|
|
|
SLITRK2
|
[NCBI]
|
9.06772e-06
|
|
|
FAU
|
[NCBI]
|
9.06772e-06
|
|
|
PNLIPRP2
|
[NCBI]
|
9.06772e-06
|
|
|
SLC27A5
|
[NCBI]
|
9.06772e-06
|
|
|
VPS33B
|
[NCBI]
|
9.06772e-06
|
|
|
DUSP18
|
[NCBI]
|
9.06772e-06
|
|
|
SORCS2
|
[NCBI]
|
9.06772e-06
|
|
|
SDPR
|
[NCBI]
|
9.06772e-06
|
|
|
peroxisomal proliferator-activated receptor alpha-interacting cofactor complex, 285-kd subunit
|
[NCBI]
|
9.06772e-06
|
|
|
SIGLEC10
|
[NCBI]
|
9.06772e-06
|
|
|
RBM10
|
[NCBI]
|
9.06772e-06
|
|
|
COPB2
|
[NCBI]
|
9.06772e-06
|
|
|
COASY
|
[NCBI]
|
9.06772e-06
|
|
|
SCT
|
[NCBI]
|
9.06772e-06
|
|
|
ACADL
|
[NCBI]
|
9.06772e-06
|
|
|
PACSIN1
|
[NCBI]
|
9.06772e-06
|
|
|
retinoblastoma-associated factor 600
|
[NCBI]
|
9.06772e-06
|
|
|
PTER
|
[NCBI]
|
9.06772e-06
|
|
|
MPST
|
[NCBI]
|
9.06772e-06
|
|
|
ZNF267
|
[NCBI]
|
9.06772e-06
|
|
|
CYP2R1
|
[NCBI]
|
9.06772e-06
|
|
|
PMF1
|
[NCBI]
|
9.06772e-06
|
|
|
BASP1
|
[NCBI]
|
9.06772e-06
|
|
|
PSMB10
|
[NCBI]
|
9.06772e-06
|
|
|
PES1
|
[NCBI]
|
9.06772e-06
|
|
|
LRDD
|
[NCBI]
|
9.06772e-06
|
|
|
TRAPPC3
|
[NCBI]
|
9.06772e-06
|
|
|
MASP1
|
[NCBI]
|
9.06772e-06
|
|
|
CH25H
|
[NCBI]
|
9.06772e-06
|
|
|
RND3
|
[NCBI]
|
9.06772e-06
|
|
|
CNO
|
[NCBI]
|
9.06772e-06
|
|
|
RAI14
|
[NCBI]
|
9.06772e-06
|
|
|
DDR2
|
[NCBI]
|
9.06772e-06
|
|
|
IGHE
|
[NCBI]
|
9.06772e-06
|
|
|
TXNRD3
|
[NCBI]
|
9.06772e-06
|
|
|
HGD
|
[NCBI]
|
9.06772e-06
|
|
|
GPR34
|
[NCBI]
|
9.06772e-06
|
|
|
SCAMP2
|
[NCBI]
|
9.06772e-06
|
|
|
IL17RB
|
[NCBI]
|
9.06772e-06
|
|
|
PRKACA
|
[NCBI]
|
9.06772e-06
|
|
|
LGALS9
|
[NCBI]
|
9.06772e-06
|
|
|
LRRC8
|
[NCBI]
|
9.06772e-06
|
|
|
NMOR2
|
[NCBI]
|
9.06772e-06
|
|
|
UGP2
|
[NCBI]
|
9.06772e-06
|
|
|
CYP2G1
|
[NCBI]
|
9.06772e-06
|
|
|
IGF1
|
[NCBI]
|
9.02379e-06
|
|
|
DAO
|
[NCBI]
|
9.02379e-06
|
|
|
TFRC
|
[NCBI]
|
8.97542e-06
|
|
|
DNMT1
|
[NCBI]
|
8.91173e-06
|
|
|
STAT6
|
[NCBI]
|
8.87959e-06
|
|
|
STARD3
|
[NCBI]
|
8.74759e-06
|
|
|
GNPAT
|
[NCBI]
|
8.74759e-06
|
|
|
C5R1
|
[NCBI]
|
8.74759e-06
|
|
|
GOT2
|
[NCBI]
|
8.74759e-06
|
|
|
PTPN6
|
[NCBI]
|
8.74759e-06
|
|
|
IL27RA
|
[NCBI]
|
8.74759e-06
|
|
|
SCCA1
|
[NCBI]
|
8.74759e-06
|
|
|
UBB
|
[NCBI]
|
8.74759e-06
|
|
|
danon disease
|
[NCBI]
|
8.46751e-06
|
|
|
HK1
|
[NCBI]
|
8.4525e-06
|
|
|
PLN
|
[NCBI]
|
8.15661e-06
|
|
|
SOCS3
|
[NCBI]
|
8.14779e-06
|
|
|
RNASE2
|
[NCBI]
|
8.08129e-06
|
|
|
ADRP
|
[NCBI]
|
8.05716e-06
|
|
|
INSR
|
[NCBI]
|
7.97304e-06
|
|
|
SHBG
|
[NCBI]
|
7.92944e-06
|
|
|
FGF8
|
[NCBI]
|
7.91846e-06
|
|
|
APS1
|
[NCBI]
|
7.84833e-06
|
|
|
PROK1
|
[NCBI]
|
7.83204e-06
|
|
|
IDH1
|
[NCBI]
|
7.83204e-06
|
|
|
PMM2
|
[NCBI]
|
7.83204e-06
|
|
|
AHCY
|
[NCBI]
|
7.83204e-06
|
|
|
GRB10
|
[NCBI]
|
7.83204e-06
|
|
|
AOAH
|
[NCBI]
|
7.83204e-06
|
|
|
COL18A1
|
[NCBI]
|
7.83204e-06
|
|
|
ME2
|
[NCBI]
|
7.83204e-06
|
|
|
F2R
|
[NCBI]
|
7.6818e-06
|
|
|
SPARC
|
[NCBI]
|
7.6818e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
7.50722e-06
|
|
|
mucolipidosis iiia
|
[NCBI]
|
7.50722e-06
|
|
|
GK
|
[NCBI]
|
7.2919e-06
|
|
|
MYC
|
[NCBI]
|
7.21315e-06
|
|
|
GJB2
|
[NCBI]
|
7.20323e-06
|
|
|
SLPI
|
[NCBI]
|
7.10815e-06
|
|
|
CTSD
|
[NCBI]
|
7.01757e-06
|
|
|
GCG
|
[NCBI]
|
7.01757e-06
|
|
|
PROS1
|
[NCBI]
|
7.01757e-06
|
|
|
MARCO
|
[NCBI]
|
7.01757e-06
|
|
|
LDHC
|
[NCBI]
|
7.01757e-06
|
|
|
CBR1
|
[NCBI]
|
7.01757e-06
|
|
|
FOXA2
|
[NCBI]
|
7.01757e-06
|
|
|
TFF3
|
[NCBI]
|
6.98125e-06
|
|
|
SLC4A5
|
[NCBI]
|
6.96151e-06
|
|
|
CEBPD
|
[NCBI]
|
6.96151e-06
|
|
|
COG1
|
[NCBI]
|
6.96151e-06
|
|
|
BEX1
|
[NCBI]
|
6.96151e-06
|
|
|
ABCA7
|
[NCBI]
|
6.96151e-06
|
|
|
PTGIR
|
[NCBI]
|
6.96151e-06
|
|
|
FDFT1
|
[NCBI]
|
6.96151e-06
|
|
|
UGT2B7
|
[NCBI]
|
6.96151e-06
|
|
|
COPB
|
[NCBI]
|
6.96151e-06
|
|
|
ITGA9
|
[NCBI]
|
6.96151e-06
|
|
|
ARMET
|
[NCBI]
|
6.96151e-06
|
|
|
REG1B
|
[NCBI]
|
6.96151e-06
|
|
|
TRIB3
|
[NCBI]
|
6.96151e-06
|
|
|
FEM1C
|
[NCBI]
|
6.96151e-06
|
|
|
ETFA
|
[NCBI]
|
6.96151e-06
|
|
|
NUDT1
|
[NCBI]
|
6.96151e-06
|
|
|
GCS1
|
[NCBI]
|
6.96151e-06
|
|
|
GNAI1
|
[NCBI]
|
6.96151e-06
|
|
|
lipin 1
|
[NCBI]
|
6.96151e-06
|
|
|
SCARB2
|
[NCBI]
|
6.96151e-06
|
|
|
DIO1
|
[NCBI]
|
6.96151e-06
|
|
|
MKKS
|
[NCBI]
|
6.96151e-06
|
|
|
BCL2L10
|
[NCBI]
|
6.96151e-06
|
|
|
RPS2
|
[NCBI]
|
6.96151e-06
|
|
|
nuclear transport factor 2
|
[NCBI]
|
6.96151e-06
|
|
|
MIB1
|
[NCBI]
|
6.96151e-06
|
|
|
MGAT5
|
[NCBI]
|
6.96151e-06
|
|
|
KLK2
|
[NCBI]
|
6.96151e-06
|
|
|
MOCS2
|
[NCBI]
|
6.96151e-06
|
|
|
BLOC1S1
|
[NCBI]
|
6.96151e-06
|
|
|
ST3GAL1
|
[NCBI]
|
6.96151e-06
|
|
|
PRKAA1
|
[NCBI]
|
6.96151e-06
|
|
|
HEMGN
|
[NCBI]
|
6.96151e-06
|
|
|
ABCG8
|
[NCBI]
|
6.96151e-06
|
|
|
MEA1
|
[NCBI]
|
6.96151e-06
|
|
|
GLG1
|
[NCBI]
|
6.96151e-06
|
|
|
CXCR6
|
[NCBI]
|
6.96151e-06
|
|
|
DDX48
|
[NCBI]
|
6.96151e-06
|
|
|
RNPEP
|
[NCBI]
|
6.96151e-06
|
|
|
CIAPIN1
|
[NCBI]
|
6.96151e-06
|
|
|
SYVN1
|
[NCBI]
|
6.96151e-06
|
|
|
HRH4
|
[NCBI]
|
6.96151e-06
|
|
|
FDPS
|
[NCBI]
|
6.96151e-06
|
|
|
PEX16
|
[NCBI]
|
6.96151e-06
|
|
|
ADIPOR2
|
[NCBI]
|
6.96151e-06
|
|
|
SLC35A1
|
[NCBI]
|
6.96151e-06
|
|
|
SCAMP1
|
[NCBI]
|
6.96151e-06
|
|
|
RAE1
|
[NCBI]
|
6.96151e-06
|
|
|
PKD2L1
|
[NCBI]
|
6.96151e-06
|
|
|
CGN
|
[NCBI]
|
6.96151e-06
|
|
|
MTHFD2
|
[NCBI]
|
6.96151e-06
|
|
|
ARHGAP21
|
[NCBI]
|
6.96151e-06
|
|
|
RPL8
|
[NCBI]
|
6.96151e-06
|
|
|
ELAVL1
|
[NCBI]
|
6.96151e-06
|
|
|
RPL37
|
[NCBI]
|
6.96151e-06
|
|
|
PTGFRN
|
[NCBI]
|
6.96151e-06
|
|
|
DDO
|
[NCBI]
|
6.96151e-06
|
|
|
PDE1B
|
[NCBI]
|
6.96151e-06
|
|
|
BZRP
|
[NCBI]
|
6.96151e-06
|
|
|
ARG2
|
[NCBI]
|
6.96151e-06
|
|
|
OSBPL5
|
[NCBI]
|
6.96151e-06
|
|
|
PCM1
|
[NCBI]
|
6.96151e-06
|
|
|
STARD13
|
[NCBI]
|
6.96151e-06
|
|
|
PTK7
|
[NCBI]
|
6.96151e-06
|
|
|
ZRF1
|
[NCBI]
|
6.96151e-06
|
|
|
GSTA2
|
[NCBI]
|
6.96151e-06
|
|
|
ADAMTS9
|
[NCBI]
|
6.96151e-06
|
|
|
SLC28A1
|
[NCBI]
|
6.96151e-06
|
|
|
KMO
|
[NCBI]
|
6.96151e-06
|
|
|
BMP3
|
[NCBI]
|
6.96151e-06
|
|
|
CRMP1
|
[NCBI]
|
6.96151e-06
|
|
|
LGALS13
|
[NCBI]
|
6.96151e-06
|
|
|
HTR2B
|
[NCBI]
|
6.96151e-06
|
|
|
B4GALNT1
|
[NCBI]
|
6.96151e-06
|
|
|
ALDH1A3
|
[NCBI]
|
6.96151e-06
|
|
|
PHF17
|
[NCBI]
|
6.96151e-06
|
|
|
C4BPA
|
[NCBI]
|
6.96151e-06
|
|
|
CLDN7
|
[NCBI]
|
6.96151e-06
|
|
|
FBXL3
|
[NCBI]
|
6.96151e-06
|
|
|
MAP3K5
|
[NCBI]
|
6.93458e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
6.76742e-06
|
|
|
NOTCH1
|
[NCBI]
|
6.75102e-06
|
|
|
HEMB
|
[NCBI]
|
6.73372e-06
|
|
|
IL4
|
[NCBI]
|
6.50584e-06
|
|
|
ESR1
|
[NCBI]
|
6.29583e-06
|
|
|
factor v deficiency
|
[NCBI]
|
6.2891e-06
|
|
|
SOCS2
|
[NCBI]
|
6.2891e-06
|
|
|
SELP
|
[NCBI]
|
6.2891e-06
|
|
|
coproporphyria
|
[NCBI]
|
6.27631e-06
|
|
|
IAPP
|
[NCBI]
|
6.21134e-06
|
|
|
NMU
|
[NCBI]
|
6.07097e-06
|
|
|
LOX
|
[NCBI]
|
6.07097e-06
|
|
|
HAE
|
[NCBI]
|
5.85513e-06
|
|
|
PHA
|
[NCBI]
|
5.85513e-06
|
|
|
EFE
|
[NCBI]
|
5.85513e-06
|
|
|
ALPS
|
[NCBI]
|
5.8404e-06
|
|
|
PEPD
|
[NCBI]
|
5.81609e-06
|
|
|
JARID2
|
[NCBI]
|
5.63468e-06
|
|
|
HMOX1
|
[NCBI]
|
5.63468e-06
|
|
|
BAK1
|
[NCBI]
|
5.63468e-06
|
|
|
GCH1
|
[NCBI]
|
5.63468e-06
|
|
|
BTC
|
[NCBI]
|
5.62704e-06
|
|
|
LEP
|
[NCBI]
|
5.61205e-06
|
|
|
KDR
|
[NCBI]
|
5.59498e-06
|
|
|
CGD
|
[NCBI]
|
5.53141e-06
|
|
|
PPIF
|
[NCBI]
|
5.48276e-06
|
|
|
GPR44
|
[NCBI]
|
5.48276e-06
|
|
|
TPP2
|
[NCBI]
|
5.48276e-06
|
|
|
PFKFB3
|
[NCBI]
|
5.48276e-06
|
|
|
RNASEN
|
[NCBI]
|
5.48276e-06
|
|
|
H2AFY
|
[NCBI]
|
5.48276e-06
|
|
|
DHCR24
|
[NCBI]
|
5.48276e-06
|
|
|
TNFRSF12A
|
[NCBI]
|
5.48276e-06
|
|
|
MRC1
|
[NCBI]
|
5.48276e-06
|
|
|
PDE3B
|
[NCBI]
|
5.48276e-06
|
|
|
ARAF1
|
[NCBI]
|
5.48276e-06
|
|
|
PMPCB
|
[NCBI]
|
5.48276e-06
|
|
|
DBP
|
[NCBI]
|
5.48276e-06
|
|
|
DPYSL3
|
[NCBI]
|
5.48276e-06
|
|
|
BCKDHB
|
[NCBI]
|
5.48276e-06
|
|
|
GP2
|
[NCBI]
|
5.48276e-06
|
|
|
VTN
|
[NCBI]
|
5.48276e-06
|
|
|
ASPH
|
[NCBI]
|
5.48276e-06
|
|
|
TLR10
|
[NCBI]
|
5.48276e-06
|
|
|
MYO10
|
[NCBI]
|
5.48276e-06
|
|
|
COQ2
|
[NCBI]
|
5.48276e-06
|
|
|
AGL
|
[NCBI]
|
5.48276e-06
|
|
|
MAN2A1
|
[NCBI]
|
5.48276e-06
|
|
|
SENP2
|
[NCBI]
|
5.48276e-06
|
|
|
OSBPL2
|
[NCBI]
|
5.48276e-06
|
|
|
MCM3AP
|
[NCBI]
|
5.48276e-06
|
|
|
TJP2
|
[NCBI]
|
5.48276e-06
|
|
|
KLF15
|
[NCBI]
|
5.48276e-06
|
|
|
CYP2B6
|
[NCBI]
|
5.48276e-06
|
|
|
ABCC9
|
[NCBI]
|
5.48276e-06
|
|
|
STMN2
|
[NCBI]
|
5.48276e-06
|
|
|
CSK
|
[NCBI]
|
5.48276e-06
|
|
|
AGPS
|
[NCBI]
|
5.48276e-06
|
|
|
HRC
|
[NCBI]
|
5.48276e-06
|
|
|
CCDC88A
|
[NCBI]
|
5.48276e-06
|
|
|
SLC22A9
|
[NCBI]
|
5.48276e-06
|
|
|
GNB1
|
[NCBI]
|
5.48276e-06
|
|
|
ZC3HAV1
|
[NCBI]
|
5.48276e-06
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
5.48276e-06
|
|
|
RUVBL1
|
[NCBI]
|
5.48276e-06
|
|
|
BLVRA
|
[NCBI]
|
5.48276e-06
|
|
|
PPARGC1B
|
[NCBI]
|
5.48276e-06
|
|
|
APOA4
|
[NCBI]
|
5.48276e-06
|
|
|
ATE1
|
[NCBI]
|
5.48276e-06
|
|
|
COMMD1
|
[NCBI]
|
5.48276e-06
|
|
|
WNT2
|
[NCBI]
|
5.48276e-06
|
|
|
RABGGTB
|
[NCBI]
|
5.48276e-06
|
|
|
NOVA1
|
[NCBI]
|
5.48276e-06
|
|
|
SLC39A7
|
[NCBI]
|
5.48276e-06
|
|
|
hemojuvelin
|
[NCBI]
|
5.48276e-06
|
|
|
ALDH5A1
|
[NCBI]
|
5.48276e-06
|
|
|
MTF1
|
[NCBI]
|
5.48276e-06
|
|
|
complement component c1r deficiency
|
[NCBI]
|
5.48276e-06
|
|
|
ST3GAL2
|
[NCBI]
|
5.48276e-06
|
|
|
QTRT1
|
[NCBI]
|
5.48276e-06
|
|
|
HK2
|
[NCBI]
|
5.48276e-06
|
|
|
ABCD3
|
[NCBI]
|
5.48276e-06
|
|
|
FRK
|
[NCBI]
|
5.48276e-06
|
|
|
SLC25A6
|
[NCBI]
|
5.48276e-06
|
|
|
PSMB9
|
[NCBI]
|
5.48276e-06
|
|
|
FBXO2
|
[NCBI]
|
5.48276e-06
|
|
|
E4F1
|
[NCBI]
|
5.48276e-06
|
|
|
NFE2
|
[NCBI]
|
5.48276e-06
|
|
|
PHLDA2
|
[NCBI]
|
5.48276e-06
|
|
|
feline leukemia virus subgroup c receptor
|
[NCBI]
|
5.48276e-06
|
|
|
CDK2
|
[NCBI]
|
5.43414e-06
|
|
|
SDS
|
[NCBI]
|
5.41297e-06
|
|
|
CPE
|
[NCBI]
|
5.38923e-06
|
|
|
ENG
|
[NCBI]
|
5.38455e-06
|
|
|
ABCD1
|
[NCBI]
|
5.21869e-06
|
|
|
PPIA
|
[NCBI]
|
5.20914e-06
|
|
|
CEL
|
[NCBI]
|
5.19126e-06
|
|
|
obesity
|
[NCBI]
|
5.14525e-06
|
|
|
ANGPTL4
|
[NCBI]
|
5.04471e-06
|
|
|
RXRA
|
[NCBI]
|
5.04471e-06
|
|
|
RBP4
|
[NCBI]
|
5.04471e-06
|
|
|
SLC16A2
|
[NCBI]
|
5.04471e-06
|
|
|
GLUD1
|
[NCBI]
|
5.04471e-06
|
|
|
CD1D
|
[NCBI]
|
5.04471e-06
|
|
|
MVK
|
[NCBI]
|
5.04471e-06
|
|
|
CEACAM1
|
[NCBI]
|
4.94886e-06
|
|
|
UGB
|
[NCBI]
|
4.85447e-06
|
|
|
CYP19A1
|
[NCBI]
|
4.7642e-06
|
|
|
AHO
|
[NCBI]
|
4.60466e-06
|
|
|
CDH1
|
[NCBI]
|
4.59974e-06
|
|
|
AGTR1
|
[NCBI]
|
4.59974e-06
|
|
|
IL6
|
[NCBI]
|
4.55697e-06
|
|
|
FBN1
|
[NCBI]
|
4.55414e-06
|
|
|
JAK3
|
[NCBI]
|
4.55414e-06
|
|
|
von willebrand disease
|
[NCBI]
|
4.55414e-06
|
|
|
REG3A
|
[NCBI]
|
4.55414e-06
|
|
|
JAK2
|
[NCBI]
|
4.54399e-06
|
|
|
LGALS3
|
[NCBI]
|
4.51134e-06
|
|
|
factor x deficiency
|
[NCBI]
|
4.51134e-06
|
|
|
NEU1
|
[NCBI]
|
4.51134e-06
|
|
|
TCF3
|
[NCBI]
|
4.51134e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
4.50292e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
4.50292e-06
|
|
|
CLTA
|
[NCBI]
|
4.37358e-06
|
|
|
PDE4B
|
[NCBI]
|
4.37358e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
4.37358e-06
|
|
|
ACAT2
|
[NCBI]
|
4.37358e-06
|
|
|
SEC14L2
|
[NCBI]
|
4.37358e-06
|
|
|
IL13RA2
|
[NCBI]
|
4.37358e-06
|
|
|
PI9
|
[NCBI]
|
4.37358e-06
|
|
|
TEGT
|
[NCBI]
|
4.37358e-06
|
|
|
TXNRD2
|
[NCBI]
|
4.37358e-06
|
|
|
TRPV4
|
[NCBI]
|
4.37358e-06
|
|
|
IGFBP4
|
[NCBI]
|
4.37358e-06
|
|
|
MAP3K7IP2
|
[NCBI]
|
4.37358e-06
|
|
|
NDST1
|
[NCBI]
|
4.37358e-06
|
|
|
SRD5A2
|
[NCBI]
|
4.37358e-06
|
|
|
LTB4R2
|
[NCBI]
|
4.37358e-06
|
|
|
CLEC4A
|
[NCBI]
|
4.37358e-06
|
|
|
SRD5A1
|
[NCBI]
|
4.37358e-06
|
|
|
SGTA
|
[NCBI]
|
4.37358e-06
|
|
|
VAMP8
|
[NCBI]
|
4.37358e-06
|
|
|
PER3
|
[NCBI]
|
4.37358e-06
|
|
|
odorant-binding protein
|
[NCBI]
|
4.37358e-06
|
|
|
NFIA
|
[NCBI]
|
4.37358e-06
|
|
|
RBBP9
|
[NCBI]
|
4.37358e-06
|
|
|
MLLT2
|
[NCBI]
|
4.37358e-06
|
|
|
DPYSL2
|
[NCBI]
|
4.37358e-06
|
|
|
RBX1
|
[NCBI]
|
4.37358e-06
|
|
|
CCR1
|
[NCBI]
|
4.37358e-06
|
|
|
UBE2D1
|
[NCBI]
|
4.37358e-06
|
|
|
IGLL1
|
[NCBI]
|
4.37358e-06
|
|
|
RDX
|
[NCBI]
|
4.37358e-06
|
|
|
PCK1
|
[NCBI]
|
4.37358e-06
|
|
|
MCRS1
|
[NCBI]
|
4.37358e-06
|
|
|
PRKG1
|
[NCBI]
|
4.37358e-06
|
|
|
ACVR1
|
[NCBI]
|
4.37358e-06
|
|
|
PXF
|
[NCBI]
|
4.37358e-06
|
|
|
UGT2B4
|
[NCBI]
|
4.37358e-06
|
|
|
DLC1
|
[NCBI]
|
4.37358e-06
|
|
|
TXNRD1
|
[NCBI]
|
4.37358e-06
|
|
|
ADAM2
|
[NCBI]
|
4.37358e-06
|
|
|
NOXO1
|
[NCBI]
|
4.37358e-06
|
|
|
MAML2
|
[NCBI]
|
4.37358e-06
|
|
|
P2RY14
|
[NCBI]
|
4.37358e-06
|
|
|
NOX4
|
[NCBI]
|
4.37358e-06
|
|
|
ADSS
|
[NCBI]
|
4.37358e-06
|
|
|
MKL1
|
[NCBI]
|
4.37358e-06
|
|
|
ARFIP2
|
[NCBI]
|
4.37358e-06
|
|
|
NCR3
|
[NCBI]
|
4.37358e-06
|
|
|
UGT2B17
|
[NCBI]
|
4.37358e-06
|
|
|
CRAT
|
[NCBI]
|
4.37358e-06
|
|
|
PTPRE
|
[NCBI]
|
4.37358e-06
|
|
|
TALDO1
|
[NCBI]
|
4.37358e-06
|
|
|
AGRP
|
[NCBI]
|
4.37358e-06
|
|
|
IL32
|
[NCBI]
|
4.37358e-06
|
|
|
MPG
|
[NCBI]
|
4.37358e-06
|
|
|
EIF4G2
|
[NCBI]
|
4.37358e-06
|
|
|
TTPA
|
[NCBI]
|
4.37358e-06
|
|
|
ART4
|
[NCBI]
|
4.37358e-06
|
|
|
ELF3
|
[NCBI]
|
4.37358e-06
|
|
|
CETP
|
[NCBI]
|
4.37358e-06
|
|
|
DNASE1
|
[NCBI]
|
4.37358e-06
|
|
|
FGB
|
[NCBI]
|
4.37358e-06
|
|
|
MAP6
|
[NCBI]
|
4.37358e-06
|
|
|
CHAD
|
[NCBI]
|
4.37358e-06
|
|
|
EEF1A2
|
[NCBI]
|
4.37358e-06
|
|
|
SLC22A4
|
[NCBI]
|
4.37358e-06
|
|
|
ITGB2
|
[NCBI]
|
4.34651e-06
|
|
|
CTSL
|
[NCBI]
|
4.34651e-06
|
|
|
TP53
|
[NCBI]
|
4.24478e-06
|
|
|
SOCS1
|
[NCBI]
|
4.24309e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
4.24309e-06
|
|
|
MMP2
|
[NCBI]
|
4.1414e-06
|
|
|
MAOA
|
[NCBI]
|
4.1414e-06
|
|
|
MC1R
|
[NCBI]
|
4.1414e-06
|
|
|
hemophilia a
|
[NCBI]
|
4.1414e-06
|
|
|
FRDA
|
[NCBI]
|
4.0756e-06
|
|
|
TLR9
|
[NCBI]
|
4.05644e-06
|
|
|
ERCC1
|
[NCBI]
|
4.02807e-06
|
|
|
PPARD
|
[NCBI]
|
4.02807e-06
|
|
|
CASP8
|
[NCBI]
|
4.02807e-06
|
|
|
EEA1
|
[NCBI]
|
4.02807e-06
|
|
|
LRP5
|
[NCBI]
|
4.02807e-06
|
|
|
KL
|
[NCBI]
|
4.02807e-06
|
|
|
BWS
|
[NCBI]
|
3.92536e-06
|
|
|
NPHP1
|
[NCBI]
|
3.922e-06
|
|
|
MAP1B
|
[NCBI]
|
3.73912e-06
|
|
|
HBB
|
[NCBI]
|
3.6296e-06
|
|
|
TIMP1
|
[NCBI]
|
3.59396e-06
|
|
|
HRG
|
[NCBI]
|
3.59396e-06
|
|
|
IRF1
|
[NCBI]
|
3.58946e-06
|
|
|
SMPD1
|
[NCBI]
|
3.58946e-06
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
3.58946e-06
|
|
|
MUT
|
[NCBI]
|
3.58946e-06
|
|
|
LCP1
|
[NCBI]
|
3.58946e-06
|
|
|
TSHR
|
[NCBI]
|
3.54217e-06
|
|
|
DCT
|
[NCBI]
|
3.54217e-06
|
|
|
SRY
|
[NCBI]
|
3.51575e-06
|
|
|
VNN1
|
[NCBI]
|
3.5086e-06
|
|
|
CLDN4
|
[NCBI]
|
3.5086e-06
|
|
|
CLCN3
|
[NCBI]
|
3.5086e-06
|
|
|
LIPG
|
[NCBI]
|
3.5086e-06
|
|
|
ARF3
|
[NCBI]
|
3.5086e-06
|
|
|
GDA
|
[NCBI]
|
3.5086e-06
|
|
|
FGF14
|
[NCBI]
|
3.5086e-06
|
|
|
VAMP1
|
[NCBI]
|
3.5086e-06
|
|
|
APOH
|
[NCBI]
|
3.5086e-06
|
|
|
LAMP1
|
[NCBI]
|
3.5086e-06
|
|
|
LTBR
|
[NCBI]
|
3.5086e-06
|
|
|
LPIN2
|
[NCBI]
|
3.5086e-06
|
|
|
RPS25
|
[NCBI]
|
3.5086e-06
|
|
|
CSRP2
|
[NCBI]
|
3.5086e-06
|
|
|
RBL1
|
[NCBI]
|
3.5086e-06
|
|
|
INPPL1
|
[NCBI]
|
3.5086e-06
|
|
|
GNB2L1
|
[NCBI]
|
3.5086e-06
|
|
|
PDE4A
|
[NCBI]
|
3.5086e-06
|
|
|
ABCD2
|
[NCBI]
|
3.5086e-06
|
|
|
BCKDHA
|
[NCBI]
|
3.5086e-06
|
|
|
BBS4
|
[NCBI]
|
3.5086e-06
|
|
|
CCL20
|
[NCBI]
|
3.5086e-06
|
|
|
PCNT1
|
[NCBI]
|
3.5086e-06
|
|
|
HBE1
|
[NCBI]
|
3.5086e-06
|
|
|
DUT
|
[NCBI]
|
3.5086e-06
|
|
|
M6PR
|
[NCBI]
|
3.5086e-06
|
|
|
DUSP5
|
[NCBI]
|
3.5086e-06
|
|
|
CA3
|
[NCBI]
|
3.5086e-06
|
|
|
MAP2K4
|
[NCBI]
|
3.5086e-06
|
|
|
SDC3
|
[NCBI]
|
3.5086e-06
|
|
|
CYP4A11
|
[NCBI]
|
3.5086e-06
|
|
|
CCR9
|
[NCBI]
|
3.5086e-06
|
|
|
ICMT
|
[NCBI]
|
3.5086e-06
|
|
|
BCL11A
|
[NCBI]
|
3.5086e-06
|
|
|
FACL2
|
[NCBI]
|
3.5086e-06
|
|
|
EDG3
|
[NCBI]
|
3.5086e-06
|
|
|
BMP5
|
[NCBI]
|
3.5086e-06
|
|
|
FABP4
|
[NCBI]
|
3.5086e-06
|
|
|
RXRG
|
[NCBI]
|
3.5086e-06
|
|
|
ERAF
|
[NCBI]
|
3.5086e-06
|
|
|
LIG1
|
[NCBI]
|
3.5086e-06
|
|
|
GCLC
|
[NCBI]
|
3.5086e-06
|
|
|
KLRA1
|
[NCBI]
|
3.5086e-06
|
|
|
PSPH
|
[NCBI]
|
3.5086e-06
|
|
|
TACSTD2
|
[NCBI]
|
3.5086e-06
|
|
|
PON2
|
[NCBI]
|
3.5086e-06
|
|
|
SLC10A2
|
[NCBI]
|
3.5086e-06
|
|
|
TYMS
|
[NCBI]
|
3.4033e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
3.39713e-06
|
|
|
ABCG2
|
[NCBI]
|
3.38189e-06
|
|
|
DFFB
|
[NCBI]
|
3.34815e-06
|
|
|
BRCA2
|
[NCBI]
|
3.34815e-06
|
|
|
CD47
|
[NCBI]
|
3.34815e-06
|
|
|
SH2D1A
|
[NCBI]
|
3.34815e-06
|
|
|
PARG
|
[NCBI]
|
3.34815e-06
|
|
|
HPS
|
[NCBI]
|
3.18898e-06
|
|
|
TNFSF6
|
[NCBI]
|
3.00233e-06
|
|
|
PBD
|
[NCBI]
|
2.92366e-06
|
|
|
PCTT
|
[NCBI]
|
2.92366e-06
|
|
|
PCI
|
[NCBI]
|
2.91048e-06
|
|
|
FAAH
|
[NCBI]
|
2.88603e-06
|
|
|
PNPLA6
|
[NCBI]
|
2.86848e-06
|
|
|
G6PC2
|
[NCBI]
|
2.82853e-06
|
|
|
ALPP
|
[NCBI]
|
2.82853e-06
|
|
|
APEX
|
[NCBI]
|
2.82853e-06
|
|
|
ADK
|
[NCBI]
|
2.82853e-06
|
|
|
CRY2
|
[NCBI]
|
2.82853e-06
|
|
|
TYK2
|
[NCBI]
|
2.81718e-06
|
|
|
NDUFS4
|
[NCBI]
|
2.81718e-06
|
|
|
srebp cleavage-activating protein
|
[NCBI]
|
2.81718e-06
|
|
|
RXRB
|
[NCBI]
|
2.81718e-06
|
|
|
HSD17B6
|
[NCBI]
|
2.81718e-06
|
|
|
MCL1
|
[NCBI]
|
2.81718e-06
|
|
|
NOTCH2
|
[NCBI]
|
2.81718e-06
|
|
|
PITPN
|
[NCBI]
|
2.81718e-06
|
|
|
AMOT
|
[NCBI]
|
2.81718e-06
|
|
|
HMGCR
|
[NCBI]
|
2.81718e-06
|
|
|
NT5C
|
[NCBI]
|
2.81718e-06
|
|
|
GGCX
|
[NCBI]
|
2.81718e-06
|
|
|
COL15A1
|
[NCBI]
|
2.81718e-06
|
|
|
APOA2
|
[NCBI]
|
2.81718e-06
|
|
|
NTS
|
[NCBI]
|
2.81718e-06
|
|
|
ERCC4
|
[NCBI]
|
2.81718e-06
|
|
|
MGAT1
|
[NCBI]
|
2.81718e-06
|
|
|
C1QR1
|
[NCBI]
|
2.81718e-06
|
|
|
ITPA
|
[NCBI]
|
2.81718e-06
|
|
|
VEGFB
|
[NCBI]
|
2.81718e-06
|
|
|
CLCN7
|
[NCBI]
|
2.81718e-06
|
|
|
RPL5
|
[NCBI]
|
2.81718e-06
|
|
|
RAD50
|
[NCBI]
|
2.81718e-06
|
|
|
PGAM1
|
[NCBI]
|
2.81718e-06
|
|
|
DGUOK
|
[NCBI]
|
2.81718e-06
|
|
|
GPD2
|
[NCBI]
|
2.81718e-06
|
|
|
JUNB
|
[NCBI]
|
2.81718e-06
|
|
|
CCS
|
[NCBI]
|
2.81718e-06
|
|
|
SLC22A2
|
[NCBI]
|
2.81718e-06
|
|
|
ADAMTS13
|
[NCBI]
|
2.81718e-06
|
|
|
CYP3A5
|
[NCBI]
|
2.81718e-06
|
|
|
TNFSF14
|
[NCBI]
|
2.81718e-06
|
|
|
TEP1
|
[NCBI]
|
2.81718e-06
|
|
|
NFKB1
|
[NCBI]
|
2.78503e-06
|
|
|
PDHA1
|
[NCBI]
|
2.76251e-06
|
|
|
SLC2A4
|
[NCBI]
|
2.65313e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.60748e-06
|
|
|
HS
|
[NCBI]
|
2.6041e-06
|
|
|
RELN
|
[NCBI]
|
2.6041e-06
|
|
|
TRAF2
|
[NCBI]
|
2.51914e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
2.51914e-06
|
|
|
SLC25A4
|
[NCBI]
|
2.49891e-06
|
|
|
melanoma, uveal
|
[NCBI]
|
2.49746e-06
|
|
|
EVC
|
[NCBI]
|
2.49746e-06
|
|
|
FOXP3
|
[NCBI]
|
2.46516e-06
|
|
|
GJA1
|
[NCBI]
|
2.46482e-06
|
|
|
ARF6
|
[NCBI]
|
2.4268e-06
|
|
|
PROCR
|
[NCBI]
|
2.4268e-06
|
|
|
CLU
|
[NCBI]
|
2.42061e-06
|
|
|
GIST
|
[NCBI]
|
2.33857e-06
|
|
|
THPO
|
[NCBI]
|
2.32563e-06
|
|
|
IGF2
|
[NCBI]
|
2.29116e-06
|
|
|
ACTG1
|
[NCBI]
|
2.25553e-06
|
|
|
TNFAIP3
|
[NCBI]
|
2.25553e-06
|
|
|
GCLM
|
[NCBI]
|
2.25553e-06
|
|
|
VIL
|
[NCBI]
|
2.25553e-06
|
|
|
C1NH
|
[NCBI]
|
2.25553e-06
|
|
|
PLCB3
|
[NCBI]
|
2.25553e-06
|
|
|
RPS6KB1
|
[NCBI]
|
2.25553e-06
|
|
|
SOD3
|
[NCBI]
|
2.25553e-06
|
|
|
PHKA1
|
[NCBI]
|
2.25553e-06
|
|
|
PEX13
|
[NCBI]
|
2.25553e-06
|
|
|
PRKAG2
|
[NCBI]
|
2.25553e-06
|
|
|
CHRD
|
[NCBI]
|
2.25553e-06
|
|
|
PDCD6IP
|
[NCBI]
|
2.25553e-06
|
|
|
CAPN10
|
[NCBI]
|
2.25553e-06
|
|
|
PDZK1
|
[NCBI]
|
2.25553e-06
|
|
|
CD81
|
[NCBI]
|
2.25553e-06
|
|
|
ADAR
|
[NCBI]
|
2.25553e-06
|
|
|
PRM1
|
[NCBI]
|
2.25553e-06
|
|
|
ICSBP1
|
[NCBI]
|
2.25553e-06
|
|
|
PNN
|
[NCBI]
|
2.25553e-06
|
|
|
CD34
|
[NCBI]
|
2.25553e-06
|
|
|
TPH1
|
[NCBI]
|
2.25553e-06
|
|
|
PDXK
|
[NCBI]
|
2.25553e-06
|
|
|
BAG4
|
[NCBI]
|
2.25553e-06
|
|
|
CMKLR1
|
[NCBI]
|
2.25553e-06
|
|
|
TEF
|
[NCBI]
|
2.25553e-06
|
|
|
SLC22A18
|
[NCBI]
|
2.25553e-06
|
|
|
LTB4R
|
[NCBI]
|
2.25553e-06
|
|
|
RAD21
|
[NCBI]
|
2.25553e-06
|
|
|
GSS
|
[NCBI]
|
2.25553e-06
|
|
|
SLC5A6
|
[NCBI]
|
2.25553e-06
|
|
|
AK3
|
[NCBI]
|
2.25553e-06
|
|
|
CDH13
|
[NCBI]
|
2.25553e-06
|
|
|
MEIS1
|
[NCBI]
|
2.25553e-06
|
|
|
RIPK1
|
[NCBI]
|
2.25331e-06
|
|
|
LHCGR
|
[NCBI]
|
2.25331e-06
|
|
|
FLT1
|
[NCBI]
|
2.19914e-06
|
|
|
KITLG
|
[NCBI]
|
2.1296e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
2.1149e-06
|
|
|
MM
|
[NCBI]
|
2.1149e-06
|
|
|
hyperglycerolemia
|
[NCBI]
|
2.1149e-06
|
|
|
EIF4E
|
[NCBI]
|
2.08381e-06
|
|
|
MYH11
|
[NCBI]
|
2.08381e-06
|
|
|
MST1
|
[NCBI]
|
2.07778e-06
|
|
|
MEN1
|
[NCBI]
|
2.05522e-06
|
|
|
STAT5A
|
[NCBI]
|
2.03564e-06
|
|
|
EPOR
|
[NCBI]
|
2.03254e-06
|
|
|
PIAS1
|
[NCBI]
|
1.92668e-06
|
|
|
CREB1
|
[NCBI]
|
1.92668e-06
|
|
|
CREBBP
|
[NCBI]
|
1.9185e-06
|
|
|
SPTA1
|
[NCBI]
|
1.9185e-06
|
|
|
UCP3
|
[NCBI]
|
1.82328e-06
|
|
|
VCP
|
[NCBI]
|
1.80878e-06
|
|
|
CD3G
|
[NCBI]
|
1.79461e-06
|
|
|
CXCL9
|
[NCBI]
|
1.79461e-06
|
|
|
ERN1
|
[NCBI]
|
1.79461e-06
|
|
|
SLC29A1
|
[NCBI]
|
1.79461e-06
|
|
|
EDG1
|
[NCBI]
|
1.79461e-06
|
|
|
BCAR1
|
[NCBI]
|
1.79461e-06
|
|
|
PEX12
|
[NCBI]
|
1.79461e-06
|
|
|
NES
|
[NCBI]
|
1.79461e-06
|
|
|
AGRN
|
[NCBI]
|
1.79461e-06
|
|
|
FXR1
|
[NCBI]
|
1.79461e-06
|
|
|
FGF18
|
[NCBI]
|
1.79461e-06
|
|
|
METAP2
|
[NCBI]
|
1.79461e-06
|
|
|
PEX5
|
[NCBI]
|
1.79461e-06
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
1.79461e-06
|
|
|
SFRP4
|
[NCBI]
|
1.79461e-06
|
|
|
ZFPM2
|
[NCBI]
|
1.79461e-06
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.79461e-06
|
|
|
CSF3R
|
[NCBI]
|
1.79461e-06
|
|
|
CYP1B1
|
[NCBI]
|
1.79461e-06
|
|
|
ECGF1
|
[NCBI]
|
1.79461e-06
|
|
|
EREG
|
[NCBI]
|
1.79461e-06
|
|
|
DGAT1
|
[NCBI]
|
1.79461e-06
|
|
|
EN2
|
[NCBI]
|
1.79461e-06
|
|
|
NPAS2
|
[NCBI]
|
1.79461e-06
|
|
|
NFE2L2
|
[NCBI]
|
1.79461e-06
|
|
|
PRKCE
|
[NCBI]
|
1.79461e-06
|
|
|
F12
|
[NCBI]
|
1.79461e-06
|
|
|
DSTN
|
[NCBI]
|
1.75758e-06
|
|
|
WAS
|
[NCBI]
|
1.75758e-06
|
|
|
CSF2
|
[NCBI]
|
1.69197e-06
|
|
|
HGFAC
|
[NCBI]
|
1.6793e-06
|
|
|
NSF
|
[NCBI]
|
1.65388e-06
|
|
|
CHS
|
[NCBI]
|
1.6185e-06
|
|
|
ERBB2
|
[NCBI]
|
1.60128e-06
|
|
|
TPT1
|
[NCBI]
|
1.60128e-06
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
1.60128e-06
|
|
|
CSF3
|
[NCBI]
|
1.60128e-06
|
|
|
SLC1A2
|
[NCBI]
|
1.60128e-06
|
|
|
MAPK14
|
[NCBI]
|
1.60128e-06
|
|
|
CDK4
|
[NCBI]
|
1.53268e-06
|
|
|
CTGF
|
[NCBI]
|
1.50347e-06
|
|
|
CFB
|
[NCBI]
|
1.45501e-06
|
|
|
CAV1
|
[NCBI]
|
1.45501e-06
|
|
|
DES
|
[NCBI]
|
1.44984e-06
|
|
|
CRC
|
[NCBI]
|
1.42681e-06
|
|
|
IVD
|
[NCBI]
|
1.41417e-06
|
|
|
CD82
|
[NCBI]
|
1.41417e-06
|
|
|
CRP
|
[NCBI]
|
1.41417e-06
|
|
|
SGK
|
[NCBI]
|
1.41417e-06
|
|
|
B4GALT1
|
[NCBI]
|
1.41417e-06
|
|
|
APOC1
|
[NCBI]
|
1.41417e-06
|
|
|
CAST
|
[NCBI]
|
1.41417e-06
|
|
|
SDHC
|
[NCBI]
|
1.41417e-06
|
|
|
ASIP
|
[NCBI]
|
1.41417e-06
|
|
|
PLIN
|
[NCBI]
|
1.41417e-06
|
|
|
TRAF1
|
[NCBI]
|
1.41417e-06
|
|
|
LU
|
[NCBI]
|
1.41417e-06
|
|
|
CLDN3
|
[NCBI]
|
1.41417e-06
|
|
|
AACT
|
[NCBI]
|
1.41417e-06
|
|
|
IL23A
|
[NCBI]
|
1.41417e-06
|
|
|
ACO2
|
[NCBI]
|
1.41417e-06
|
|
|
RALGDS
|
[NCBI]
|
1.41417e-06
|
|
|
PAPSS2
|
[NCBI]
|
1.41417e-06
|
|
|
CPT2
|
[NCBI]
|
1.41417e-06
|
|
|
CTSG
|
[NCBI]
|
1.41417e-06
|
|
|
DAB2
|
[NCBI]
|
1.41417e-06
|
|
|
HTR2A
|
[NCBI]
|
1.41417e-06
|
|
|
NQO1
|
[NCBI]
|
1.41417e-06
|
|
|
REG1A
|
[NCBI]
|
1.41417e-06
|
|
|
APH
|
[NCBI]
|
1.41417e-06
|
|
|
MBTPS2
|
[NCBI]
|
1.41417e-06
|
|
|
RANBP1
|
[NCBI]
|
1.41417e-06
|
|
|
KEAP1
|
[NCBI]
|
1.41417e-06
|
|
|
AIRE
|
[NCBI]
|
1.37819e-06
|
|
|
HMGB1
|
[NCBI]
|
1.35647e-06
|
|
|
ADAM17
|
[NCBI]
|
1.30353e-06
|
|
|
BAX
|
[NCBI]
|
1.30353e-06
|
|
|
RUNX1
|
[NCBI]
|
1.30353e-06
|
|
|
MSTN
|
[NCBI]
|
1.30353e-06
|
|
|
HNMT
|
[NCBI]
|
1.25208e-06
|
|
|
IL18
|
[NCBI]
|
1.25208e-06
|
|
|
STAT1
|
[NCBI]
|
1.21638e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.20919e-06
|
|
|
PARP1
|
[NCBI]
|
1.20919e-06
|
|
|
HBA1
|
[NCBI]
|
1.20919e-06
|
|
|
ATF2
|
[NCBI]
|
1.16263e-06
|
|
|
IP
|
[NCBI]
|
1.14384e-06
|
|
|
MPI
|
[NCBI]
|
1.09949e-06
|
|
|
UGDH
|
[NCBI]
|
1.09949e-06
|
|
|
GPR30
|
[NCBI]
|
1.09949e-06
|
|
|
TBK1
|
[NCBI]
|
1.09949e-06
|
|
|
CSE1L
|
[NCBI]
|
1.09949e-06
|
|
|
BCL2A1
|
[NCBI]
|
1.09949e-06
|
|
|
LRAT
|
[NCBI]
|
1.09949e-06
|
|
|
pta deficiency
|
[NCBI]
|
1.09949e-06
|
|
|
SIX5
|
[NCBI]
|
1.09949e-06
|
|
|
ODC1
|
[NCBI]
|
1.09949e-06
|
|
|
APOBEC3G
|
[NCBI]
|
1.09949e-06
|
|
|
SEPT5
|
[NCBI]
|
1.09949e-06
|
|
|
FABP7
|
[NCBI]
|
1.09949e-06
|
|
|
CFI
|
[NCBI]
|
1.09949e-06
|
|
|
ADIPOR1
|
[NCBI]
|
1.09949e-06
|
|
|
PXE
|
[NCBI]
|
1.08975e-06
|
|
|
IGF1R
|
[NCBI]
|
1.06896e-06
|
|
|
STAT4
|
[NCBI]
|
1.06896e-06
|
|
|
H6PD
|
[NCBI]
|
1.06896e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
1.02745e-06
|
|
|
SLAMF1
|
[NCBI]
|
1.02745e-06
|
|
|
PAFAH1B1
|
[NCBI]
|
1.02745e-06
|
|
|
VLDLR
|
[NCBI]
|
1.02745e-06
|
|
|
TD1
|
[NCBI]
|
9.78555e-07
|
|
|
MSD
|
[NCBI]
|
9.61265e-07
|
|
|
CDPX2
|
[NCBI]
|
9.61265e-07
|
|
|
AHC
|
[NCBI]
|
9.61265e-07
|
|
|
POLG
|
[NCBI]
|
9.04237e-07
|
|
|
CRY1
|
[NCBI]
|
9.04237e-07
|
|
|
IKBKB
|
[NCBI]
|
9.04237e-07
|
|
|
TYR
|
[NCBI]
|
9.00681e-07
|
|
|
IL5
|
[NCBI]
|
8.98329e-07
|
|
|
LIFR
|
[NCBI]
|
8.98329e-07
|
|
|
UGCG
|
[NCBI]
|
8.98329e-07
|
|
|
TCRA
|
[NCBI]
|
8.98329e-07
|
|
|
GRN
|
[NCBI]
|
8.98329e-07
|
|
|
PTN
|
[NCBI]
|
8.70106e-07
|
|
|
MYO15A
|
[NCBI]
|
8.39583e-07
|
|
|
IGFBP3
|
[NCBI]
|
8.39583e-07
|
|
|
FLI1
|
[NCBI]
|
8.39583e-07
|
|
|
TCIRG1
|
[NCBI]
|
8.39583e-07
|
|
|
IL1RN
|
[NCBI]
|
8.39583e-07
|
|
|
PPOX
|
[NCBI]
|
8.39583e-07
|
|
|
FABP2
|
[NCBI]
|
8.39583e-07
|
|
|
SLC27A1
|
[NCBI]
|
8.39583e-07
|
|
|
BID
|
[NCBI]
|
8.39583e-07
|
|
|
NDN
|
[NCBI]
|
8.39583e-07
|
|
|
SURF1
|
[NCBI]
|
8.39583e-07
|
|
|
PZP
|
[NCBI]
|
8.39583e-07
|
|
|
CRYBA1
|
[NCBI]
|
8.39583e-07
|
|
|
ACO1
|
[NCBI]
|
8.39583e-07
|
|
|
DIO2
|
[NCBI]
|
8.39583e-07
|
|
|
INVS
|
[NCBI]
|
8.39583e-07
|
|
|
LNS
|
[NCBI]
|
8.26358e-07
|
|
|
alopecia, androgenetic
|
[NCBI]
|
8.26358e-07
|
|
|
ATF3
|
[NCBI]
|
8.05947e-07
|
|
|
ADIPOQ
|
[NCBI]
|
7.75628e-07
|
|
|
IL8
|
[NCBI]
|
7.75628e-07
|
|
|
PGM1
|
[NCBI]
|
7.75628e-07
|
|
|
TNFRSF14
|
[NCBI]
|
7.56677e-07
|
|
|
CFH
|
[NCBI]
|
7.0952e-07
|
|
|
FANCC
|
[NCBI]
|
6.59752e-07
|
|
|
ESR2
|
[NCBI]
|
6.59752e-07
|
|
|
HEXB
|
[NCBI]
|
6.59752e-07
|
|
|
TNFRSF6
|
[NCBI]
|
6.59752e-07
|
|
|
GC
|
[NCBI]
|
6.59752e-07
|
|
|
TGFB1
|
[NCBI]
|
6.29488e-07
|
|
|
NR4A2
|
[NCBI]
|
6.25991e-07
|
|
|
orotic aciduria i
|
[NCBI]
|
6.25991e-07
|
|
|
RGMA
|
[NCBI]
|
6.25991e-07
|
|
|
HLA-B
|
[NCBI]
|
6.25991e-07
|
|
|
SDHD
|
[NCBI]
|
6.25991e-07
|
|
|
SPR
|
[NCBI]
|
6.25991e-07
|
|
|
SOAT1
|
[NCBI]
|
6.25991e-07
|
|
|
DSCR1
|
[NCBI]
|
6.25991e-07
|
|
|
EPM2A
|
[NCBI]
|
6.25991e-07
|
|
|
GOT1
|
[NCBI]
|
6.25991e-07
|
|
|
CYCS
|
[NCBI]
|
6.25991e-07
|
|
|
MTHFR
|
[NCBI]
|
6.25991e-07
|
|
|
ALAD
|
[NCBI]
|
6.25149e-07
|
|
|
GPX1
|
[NCBI]
|
6.25149e-07
|
|
|
FOXO1A
|
[NCBI]
|
6.25149e-07
|
|
|
GCCR
|
[NCBI]
|
6.09368e-07
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
5.76613e-07
|
|
|
HBG1
|
[NCBI]
|
5.51141e-07
|
|
|
TNFRSF1B
|
[NCBI]
|
5.51141e-07
|
|
|
REN
|
[NCBI]
|
5.51141e-07
|
|
|
SLC22A6
|
[NCBI]
|
5.51141e-07
|
|
|
HDAC3
|
[NCBI]
|
5.51141e-07
|
|
|
CDC2
|
[NCBI]
|
5.48074e-07
|
|
|
HEXA
|
[NCBI]
|
5.18046e-07
|
|
|
PVR
|
[NCBI]
|
5.18046e-07
|
|
|
GLB1
|
[NCBI]
|
5.08635e-07
|
|
|
GAA
|
[NCBI]
|
5.08635e-07
|
|
|
UCP1
|
[NCBI]
|
4.64017e-07
|
|
|
PFKM
|
[NCBI]
|
4.5208e-07
|
|
|
HNF1B
|
[NCBI]
|
4.5208e-07
|
|
|
SELE
|
[NCBI]
|
4.5208e-07
|
|
|
FLT3
|
[NCBI]
|
4.5208e-07
|
|
|
GDI1
|
[NCBI]
|
4.5208e-07
|
|
|
NR4A1
|
[NCBI]
|
4.5208e-07
|
|
|
PYGM
|
[NCBI]
|
4.5208e-07
|
|
|
C4A
|
[NCBI]
|
4.5208e-07
|
|
|
PCCA
|
[NCBI]
|
4.5208e-07
|
|
|
CBFA2T1
|
[NCBI]
|
4.5208e-07
|
|
|
PIK3R1
|
[NCBI]
|
4.5208e-07
|
|
|
AQP7
|
[NCBI]
|
4.5208e-07
|
|
|
TKT
|
[NCBI]
|
4.5208e-07
|
|
|
SCNN1B
|
[NCBI]
|
4.5208e-07
|
|
|
CLDN1
|
[NCBI]
|
4.5208e-07
|
|
|
ACTB
|
[NCBI]
|
4.5208e-07
|
|
|
COL6A1
|
[NCBI]
|
4.50279e-07
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
4.50279e-07
|
|
|
PTPRC
|
[NCBI]
|
4.50279e-07
|
|
|
FN1
|
[NCBI]
|
4.50279e-07
|
|
|
ADORA3
|
[NCBI]
|
4.50279e-07
|
|
|
NP
|
[NCBI]
|
3.9972e-07
|
|
|
AK1
|
[NCBI]
|
3.57702e-07
|
|
|
PML
|
[NCBI]
|
3.57702e-07
|
|
|
UMOD
|
[NCBI]
|
3.57702e-07
|
|
|
NCOA3
|
[NCBI]
|
3.57702e-07
|
|
|
ALDH1A2
|
[NCBI]
|
3.57702e-07
|
|
|
ETV6
|
[NCBI]
|
3.57702e-07
|
|
|
IL12B
|
[NCBI]
|
3.57702e-07
|
|
|
GATA1
|
[NCBI]
|
3.57702e-07
|
|
|
SLC11A1
|
[NCBI]
|
3.57702e-07
|
|
|
TLR4
|
[NCBI]
|
3.38725e-07
|
|
|
SLC1A3
|
[NCBI]
|
3.12547e-07
|
|
|
JUN
|
[NCBI]
|
3.12547e-07
|
|
|
MTND2
|
[NCBI]
|
3.12547e-07
|
|
|
HADHA
|
[NCBI]
|
3.12547e-07
|
|
|
JMJD6
|
[NCBI]
|
3.12547e-07
|
|
|
SPG7
|
[NCBI]
|
3.12547e-07
|
|
|
EP300
|
[NCBI]
|
3.12547e-07
|
|
|
HIGM1
|
[NCBI]
|
2.9954e-07
|
|
|
XLP1
|
[NCBI]
|
2.9954e-07
|
|
|
GIP
|
[NCBI]
|
2.80746e-07
|
|
|
AQP3
|
[NCBI]
|
2.74001e-07
|
|
|
DYSF
|
[NCBI]
|
2.74001e-07
|
|
|
CYBB
|
[NCBI]
|
2.74001e-07
|
|
|
EDNRB
|
[NCBI]
|
2.74001e-07
|
|
|
TFPI
|
[NCBI]
|
2.57487e-07
|
|
|
ACP1
|
[NCBI]
|
2.40325e-07
|
|
|
ANG
|
[NCBI]
|
2.40325e-07
|
|
|
PTGS1
|
[NCBI]
|
2.03085e-07
|
|
|
CA2
|
[NCBI]
|
2.03085e-07
|
|
|
MAOB
|
[NCBI]
|
2.03085e-07
|
|
|
FGFR4
|
[NCBI]
|
2.03085e-07
|
|
|
LTC4S
|
[NCBI]
|
2.03085e-07
|
|
|
RAF1
|
[NCBI]
|
2.03085e-07
|
|
|
STK11
|
[NCBI]
|
1.99835e-07
|
|
|
CXCR4
|
[NCBI]
|
1.75397e-07
|
|
|
TLR2
|
[NCBI]
|
1.67685e-07
|
|
|
LEPR
|
[NCBI]
|
1.66274e-07
|
|
|
leber optic atrophy
|
[NCBI]
|
1.4773e-07
|
|
|
GZMB
|
[NCBI]
|
1.35936e-07
|
|
|
MTATP6
|
[NCBI]
|
1.35936e-07
|
|
|
FH
|
[NCBI]
|
1.35936e-07
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.35936e-07
|
|
|
E2F1
|
[NCBI]
|
1.35936e-07
|
|
|
ATF4
|
[NCBI]
|
1.35936e-07
|
|
|
DFFA
|
[NCBI]
|
1.35936e-07
|
|
|
STC1
|
[NCBI]
|
1.27027e-07
|
|
|
LTA
|
[NCBI]
|
1.20151e-07
|
|
|
PGM3
|
[NCBI]
|
1.20151e-07
|
|
|
MYB
|
[NCBI]
|
1.20151e-07
|
|
|
UTRN
|
[NCBI]
|
1.20151e-07
|
|
|
IL15
|
[NCBI]
|
1.20151e-07
|
|
|
CBL
|
[NCBI]
|
1.20151e-07
|
|
|
IL7R
|
[NCBI]
|
1.20151e-07
|
|
|
MTCO3
|
[NCBI]
|
1.20151e-07
|
|
|
EBP
|
[NCBI]
|
1.20151e-07
|
|
|
CTNS
|
[NCBI]
|
1.1792e-07
|
|
|
neuroblastoma
|
[NCBI]
|
1.1792e-07
|
|
|
MDLS
|
[NCBI]
|
1.1792e-07
|
|
|
LAD
|
[NCBI]
|
1.00073e-07
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.00073e-07
|
|
|
ABCB1
|
[NCBI]
|
9.52715e-08
|
|
|
APOD
|
[NCBI]
|
8.46751e-08
|
|
|
MTTK
|
[NCBI]
|
8.3127e-08
|
|
|
PRKAR1A
|
[NCBI]
|
8.3127e-08
|
|
|
GLA
|
[NCBI]
|
8.3127e-08
|
|
|
ATF6
|
[NCBI]
|
8.3127e-08
|
|
|
SCN4A
|
[NCBI]
|
8.3127e-08
|
|
|
FANCA
|
[NCBI]
|
8.3127e-08
|
|
|
GPC3
|
[NCBI]
|
8.3127e-08
|
|
|
MN
|
[NCBI]
|
8.3127e-08
|
|
|
HSPB1
|
[NCBI]
|
8.3127e-08
|
|
|
MYD88
|
[NCBI]
|
8.3127e-08
|
|
|
HLA-DRA
|
[NCBI]
|
8.3127e-08
|
|
|
SDC2
|
[NCBI]
|
7.13881e-08
|
|
|
CD36
|
[NCBI]
|
6.75849e-08
|
|
|
SN
|
[NCBI]
|
6.07924e-08
|
|
|
ID2
|
[NCBI]
|
6.07924e-08
|
|
|
PTPN11
|
[NCBI]
|
6.07924e-08
|
|
|
MTCO2
|
[NCBI]
|
6.07924e-08
|
|
|
FUS
|
[NCBI]
|
6.07924e-08
|
|
|
NR4A3
|
[NCBI]
|
6.07924e-08
|
|
|
EDA
|
[NCBI]
|
6.07924e-08
|
|
|
down syndrome
|
[NCBI]
|
5.96578e-08
|
|
|
MTAP
|
[NCBI]
|
5.35308e-08
|
|
|
STAT3
|
[NCBI]
|
5.182e-08
|
|
|
EGR1
|
[NCBI]
|
4.5052e-08
|
|
|
PKD1
|
[NCBI]
|
4.38051e-08
|
|
|
ACVRL1
|
[NCBI]
|
4.23326e-08
|
|
|
TCF7L2
|
[NCBI]
|
4.23326e-08
|
|
|
MYO7A
|
[NCBI]
|
4.23326e-08
|
|
|
MYCN
|
[NCBI]
|
4.23326e-08
|
|
|
NUP98
|
[NCBI]
|
4.23326e-08
|
|
|
CDA
|
[NCBI]
|
4.23326e-08
|
|
|
TIMP3
|
[NCBI]
|
4.23326e-08
|
|
|
TFF1
|
[NCBI]
|
4.23326e-08
|
|
|
HIPK2
|
[NCBI]
|
4.23326e-08
|
|
|
AMACR
|
[NCBI]
|
4.23326e-08
|
|
|
OPTN
|
[NCBI]
|
4.23326e-08
|
|
|
NOS2A
|
[NCBI]
|
4.23326e-08
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
4.13659e-08
|
|
|
PGK1
|
[NCBI]
|
2.92001e-08
|
|
|
SLC6A6
|
[NCBI]
|
2.92001e-08
|
|
|
SPINK1
|
[NCBI]
|
2.39836e-08
|
|
|
FGF1
|
[NCBI]
|
2.39836e-08
|
|
|
DDC
|
[NCBI]
|
2.39836e-08
|
|
|
MBL2
|
[NCBI]
|
2.35823e-08
|
|
|
PTPN1
|
[NCBI]
|
2.25237e-08
|
|
|
PEX7
|
[NCBI]
|
2.25237e-08
|
|
|
MTND5
|
[NCBI]
|
2.25237e-08
|
|
|
NOD2
|
[NCBI]
|
2.25237e-08
|
|
|
SLC7A5
|
[NCBI]
|
2.25237e-08
|
|
|
GATA4
|
[NCBI]
|
2.25237e-08
|
|
|
DM2
|
[NCBI]
|
2.15677e-08
|
|
|
KIT
|
[NCBI]
|
2.12538e-08
|
|
|
FRAP1
|
[NCBI]
|
1.94045e-08
|
|
|
TMOD
|
[NCBI]
|
1.45984e-08
|
|
|
FSTL3
|
[NCBI]
|
1.45984e-08
|
|
|
CLTC
|
[NCBI]
|
1.45984e-08
|
|
|
ITGB1
|
[NCBI]
|
1.45984e-08
|
|
|
ALDH3A2
|
[NCBI]
|
1.45984e-08
|
|
|
GZMA
|
[NCBI]
|
1.45984e-08
|
|
|
HBEGF
|
[NCBI]
|
1.45984e-08
|
|
|
NRTN
|
[NCBI]
|
1.45984e-08
|
|
|
DLK1
|
[NCBI]
|
1.45984e-08
|
|
|
MTCO1
|
[NCBI]
|
1.45984e-08
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.45984e-08
|
|
|
NCOA2
|
[NCBI]
|
1.45984e-08
|
|
|
THRB
|
[NCBI]
|
1.19892e-08
|
|
|
GH1
|
[NCBI]
|
6.4679e-09
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.69486e-09
|
|
|
RHCE
|
[NCBI]
|
3.23361e-09
|
|
|
NPC1
|
[NCBI]
|
3.23361e-09
|
|
|
SPTB
|
[NCBI]
|
3.23361e-09
|
|
|
NRP1
|
[NCBI]
|
3.23361e-09
|
|
|
C3
|
[NCBI]
|
3.23361e-09
|
|
|
DNM1L
|
[NCBI]
|
3.23361e-09
|
|
|
PAX5
|
[NCBI]
|
3.23361e-09
|
|
|
GATA3
|
[NCBI]
|
3.23361e-09
|
|
|
GHRL
|
[NCBI]
|
3.23361e-09
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
2.61592e-09
|
|
|
HHF2
|
[NCBI]
|
2.61592e-09
|
|
|
SLC16A1
|
[NCBI]
|
2.22551e-09
|
|
|
KRT20
|
[NCBI]
|
2.10261e-09
|
|
|
BTHS
|
[NCBI]
|
1.84595e-09
|
|
|
LRP2
|
[NCBI]
|
1.11263e-09
|
|
|
PLSCR1
|
[NCBI]
|
1.11263e-09
|
|
|
CCL25
|
[NCBI]
|
1.11263e-09
|
|
|
TYRP1
|
[NCBI]
|
1.11263e-09
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.11263e-09
|
|
|
SFRP1
|
[NCBI]
|
1.11263e-09
|
|
|
KLF2
|
[NCBI]
|
1.11263e-09
|
|
|
CLOCK
|
[NCBI]
|
1.11263e-09
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
7.41359e-10
|
|
|
TPMT
|
[NCBI]
|
2.59762e-10
|
|
|
ARF1
|
[NCBI]
|
2.59762e-10
|
|